In this episode, Emil and Jannik, co-founders of Immunordic share their journey of building a startup in the biotech industry.

They discuss the challenges they faced while developing a technology platform for identifying protein binders using limited resources. 

The conversation covers their initial focus on building synthetic libraries and wet lab methods, the pivot to an AI and machine learning-based approach, and the lessons learned from both successes and setbacks.

Key insights include the importance of networking, how to build a lab on a tight budget, and the value of persistence and passion in driving a startup forward. They also outline their current focus and future directions, aiming to provide accessible scientific tools for diagnostics, therapeutics, and academic research.

00:40 Founders' Backgrounds

02:29 Immunordic's Mission and Services

03:32 The Origin Story

06:08 Early Challenges and Lessons

11:17 Building the Lab

18:43 Funding and Resources

20:52 Understanding Through Teaching

21:55 Enrolling and Guiding New Lab Members

22:35 Identifying Student Drives and Aligning Projects

23:40 Challenges and Successes with Student Projects

24:39 The Pivot to In Silico Prediction

25:19 Building Synthetic Libraries and Bio Panning

26:08 Challenges with Wet Lab Services

27:50 Transitioning to Scalable Solutions

28:37 Adopting In Silico Methods

30:40 Client and Market Reactions to the Pivot

39:10 Future Plans and Collaborations

Ideas for future podcast guests or themes? 💡

We want to co-create this podcast with you. We'd therefore love to hear your suggestions for future podcast guests or themes.

Feel free to share in a private message or leave a comment below 🙏🏼

(It's also ok to invite yourself 😉)

Join Our Life Science Talent Ecosystem

We want to build a community to inspire life science professionals and leaders through talent talks and organized events. Share knowledge across the life science community through personal stories of their journey. We encourage you to take part in shaping this community by sharing your feedback, questions, or ideas. This you can do through our LinkedIn⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠community page⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠.

Warm Regards from your podcast hosts: ⁠⁠⁠⁠⁠⁠⁠⁠⁠Nehar Mortuza⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ and⁠⁠⁠ ⁠⁠⁠Søren Spanner Bach

In this conversation, Marcelina outlines a practical roadmap for AI transformation within life sciences organizations, emphasizing that real progress begins with leadership alignment and people-centric change management.

She explains that senior leaders must first gain a foundational understanding of AI—ideally becoming super users—to communicate vision, reduce uncertainty, and guide their teams effectively.

People leaders then play a crucial role in translating strategy into day-to-day meaning for employees, influencing priorities, workflows, and professional development.

Marcelina also highlights the importance of governance, data readiness, and collaboration between C-suite leaders and boards, many of whom acknowledge the need for AI upskilling.

She stresses that successful AI adoption requires tailored training, not generic programs, referencing research that shows customized learning dramatically increases the number of super users and hours saved weekly.

Throughout the discussion, she shares insights from her book It Starts With Vision, including interviews with senior leaders across pharma, data science, IT security, and organizational transformation.

She encourages leaders to begin with curiosity, assess their organization’s current maturity, and use surveys and strategic sparring to design transformations that avoid wasted investment and maximize impact.

Key Topics Covered:

00:32:38 Why messaging from senior leadership and people leaders matters most in AI transformation.

00:34:00 Building the AI roadmap: upskilling senior leaders, creating super users, and enabling informed conversations.

00:35:32 The role of boards in guiding AI strategy and the increasing need for board-level AI literacy.

00:36:53 Training leaders, preparing for employee concerns, and aligning grassroots initiatives with strategy.

00:38:32 Why organizations start at different points in their AI journey and how to avoid siloed efforts.

00:40:15 Introduction to Marcelina’s book and why AI must be treated as a human-centered transformation.

00:42:21 Interviews inside the book: data science, pharma innovation, IT security, and change leadership.

00:46:02 Where to buy the book and why it’s a limited-edition release.

00:47:31 Why generic AI guidance fails—and how job-specific training changes adoption outcomes.

00:49:20 How Marcelina uses surveys to diagnose readiness and provide targeted leadership support.

00:51:29 Final call to action: read the book, take the survey, and seek tailored support.

Notable Quotes:

“This is a people-centric transformation—employees deserve to be led well through it.”

“Senior leaders don’t need to be specialists, but they must understand AI well enough to speak its language.”

“Tailored, job-specific training creates super users—generic AI training does not.”

“We need governance that can say yes and no to grassroots AI initiatives with confidence.”

“Once employees understand AI, they become drivers of process optimization instead of blockers.”

CTA:

Download the AI readiness survey to assess your AI maturity.

Follow Marcelina on LinkedIn for weekly insights on AI, leadership, and transformation.

Get the limited-edition book It Starts With Vision before the next print run out. Exclusive treat: Apply TALENT10 at checkout for 10% off!

In this episode of Life Science Talent Talks, Søren welcomes Svend Petersen and Niels Bjerg Jensen, the pioneering co-founders of Mycoverse, to explore the entrepreneurial journey of building a life science startup that bridges cutting-edge biotechnology and sustainable agriculture.

Mycoverse is at the forefront of innovation, leveraging high-throughput screening technology to develop natural solutions for fungal disease control — tackling one of the most pressing challenges in global food security while ensuring environmental safety. But transforming a scientific breakthrough into a viable commercial venture is no small feat.

In this conversation, Svend and Niels share the origin story of Mycoverse, tracing their journey from identifying a critical gap in the market to securing exclusive technology licenses and assembling a team dedicated to reshaping the agricultural landscape. They discuss the defining moments that drove them to build this company, the biggest challenges they’ve faced—including regulatory hurdles, investor skepticism, and early-stage pivots — and the strategies they’ve used to navigate these complexities.

Svend and Niels reflect on the personal lessons learned throughout their entrepreneurial journey — the resilience, adaptability, and vision required to drive innovation in the life sciences sector. They’ll also share their outlook on the future of Mycoverse, from immediate priorities to long-term goals, and offer insights for aspiring founders navigating similar challenges in this space.

If you’re passionate about the intersection of science, entrepreneurship, and the future of sustainable agriculture, this episode is packed with valuable takeaways on what it really takes to turn groundbreaking research into a thriving startup.

Stay tuned for an inspiring and in-depth conversation with the minds behind Mycoverse, right here on Life Science Talent Talks.

Timestamps:

00:39 Introduction to Mycoverse and Its Founders

02:04 Mycoverse's Mission and Technology

03:51 The Entrepreneurial Journey

05:01 The Birth of Mycoverse

08:09 Challenges and Milestones

12:46 Business Model and Future Plans

17:06 Funding and Investor Relations

18:46 Market Opportunities and Unique Positioning

19:45 Biologicals Discovery Platform: High-Throughput Screening on Filamentous Fungi

20:09 Regulatory Approval and Market Strategy

21:09 Non-GMO and EU Market Considerations

22:14 Partnerships and Customer Dialogues

25:31 Investor Concerns and Speed to Market

29:45 Proud Moments and Team Dynamics

33:39 Future Plans and Challenges

Ideas for future podcast guests or themes? 💡

We want to co-create this podcast with you. We'd therefore love to hear your suggestions for future podcast guests or themes.

Feel free to share in a private message or leave a comment below 🙏🏼

(It's also ok to invite yourself 😉)

Join Our Life Science Talent Ecosystem

We want to build a community to inspire life science professionals and leaders through talent talks and organized events. Share knowledge across the life science community through personal stories of their journey. We encourage you to take part in shaping this community by sharing your feedback, questions, or ideas. This you can do through our LinkedIn⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠community page⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠.
Warm Regards from your podcast hosts: ⁠⁠⁠⁠⁠⁠⁠⁠⁠Nehar Mortuza⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ and⁠⁠⁠ ⁠⁠⁠Søren Spanner Bach

In this episode of Life Science Talent Talks, Nehar explores the development of a dynamic life science talent community. They are joined by Pia Petersen and Ulrik Gade, who share their expertise on agile methodologies, flow-based leadership, and organizational psychology.  

The discussion delves into their professional journeys, the founding of Agil Procesforbedring, and the challenges they have navigated. A key focus is how leadership and self-organization can foster innovation and efficiency within life science organizations. The conversation highlights the importance of transparency, trust, and continuous improvement in building engaged, high-performing teams. 

Throughout the episode, Pia and Ulrik offer practical insights and real-world examples of effective management practices applicable to both startups and large enterprises. The episode concludes with book recommendations and actionable advice for life science professionals looking to enhance leadership and organizational effectiveness.

Timestamps:

00:59 Introduction to Our Guest: Pia Petersen

02:06 Ulrik Gade Journey into Agile and Leadership

04:02 Founding Agil Procesforbedring

07:57 Challenges and Focus of the Company

09:55 Leadership and Self-Organization

17:37 Measuring the Value of Facilitation

21:14 Continuous Improvement and Action Learning

23:51 The Conscious Leader's Dilemma

24:35 Stop Starting, Start Finishing

28:19 The Importance of Transparency

30:53 Engagement and Strategy in the Workplace

33:44 Self-Organization and Task Management

35:24 Operational and Strategic Contexts

38:15 Challenges and Excitements in Leadership

43:03 Final Thoughts and Takeaways

Ideas for future podcast guests or themes? 💡

We want to co-create this podcast with you. We'd therefore love to hear your suggestions for future podcast guests or themes.

Feel free to share in a private message or leave a comment below 🙏🏼

(It's also ok to invite yourself 😉)

Join Our Life Science Talent Ecosystem

We want to build a community to inspire life science professionals and leaders through talent talks and organized events. Share knowledge across the life science community through personal stories of their journey. We encourage you to take part in shaping this community by sharing your feedback, questions, or ideas. This you can do through our LinkedIn⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠community page⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠.
Warm Regards from your podcast hosts: ⁠⁠⁠⁠⁠⁠⁠⁠⁠Nehar Mortuza⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ and⁠⁠⁠ ⁠⁠⁠Søren Spanner Bach

In this episode Dortea Engelund, COO and Co-founder of Devote Consulting, explores her journey of scaling a life sciences consultancy from a bold startup to a thriving organization. Dortea shares key insights into how Devote grew from 2 to 80 employees in just six years while maintaining a strong organizational culture and delivering exceptional value to the biotech and life sciences sector.

This conversation dives into the strategies behind effective recruitment and the art of aligning new talent with company values to foster a cohesive and productive team. Dortea reflects on her personal leadership evolution, offering candid advice on navigating the challenges of delegation, adaptability, and decision-making in a rapidly growing business.

Tune in to uncover the secrets behind building a thriving consultancy while staying true to your mission and values.

Timestamps:

00:38 Meet Dorothea: From Pharmacist to CEO

02:11 Devote Consulting: Mission and Services

05:48 Challenges and Successes in Scaling Devote

08:01 Recruitment Strategies and Company Culture

26:34 Customer-Centric Consulting Approach

27:09 Building a Healthy Company Culture

27:35 Trust and Integrity in Client Relationships

29:33 Formalizing Cultural Values

33:07 Employee Involvement and Idea Sharing

35:53 Leadership and Role Evolution

41:23 Delegation and Responsibility

48:09 Challenges and Future Directions

Ideas for future podcast guests or themes? 💡

We want to co-create this podcast with you. We'd therefore love to hear your suggestions for future podcast guests or themes.

Feel free to share in a private message or leave a comment below 🙏🏼

(It's also ok to invite yourself 😉)

Join Our Life Science Talent Ecosystem

We want to build a community to inspire life science professionals and leaders through talent talks and organized events. Share knowledge across the life science community through personal stories of their journey. We encourage you to take part in shaping this community by sharing your feedback, questions, or ideas. This you can do through our LinkedIn⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠community page⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠.

Warm Regards from your podcast hosts: ⁠⁠⁠⁠⁠⁠⁠⁠⁠Nehar Mortuza⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ and⁠⁠⁠ ⁠⁠⁠Søren Spanner Bach

In this episode, we explore the groundbreaking collaboration between Nordic BioVentures and Amass Technologies, two pioneering firms leveraging AI to supercharge innovation and venture creation.

In this episode, Will Wright, Co-Founder and Managing Partner of Nordic BioVentures, and Henrik Jensen, Co-Founder and CEO of Amass Technologies share how they are working with CSO AI-agents and how they were able to create FEESH a company making sustainable fish feed for the future of aquaculture in record time:

The FEESH founders in collaboration with AI-CSO agents were able to fast-track venture creation from idea to POC & funding in just 4 months!!!

We discuss how AI is reshaping the biotech startup landscape by enhancing efficiency, reducing costly experimentation errors, and accelerating validation timelines. The conversation also addresses key challenges in integrating AI into existing workflows, strategies for scaling their approach, and the broader implications for early-stage biotech entrepreneurs.

Will and Henrik provide insights into how AI is not just augmenting but fundamentally reshaping the venture creation process, making high-impact innovation more accessible and scalable.

Tune in for an in-depth discussion on the future of AI-driven biotech innovation and venture creation, the evolving role of human-machine collaboration, and what this means for the next generation of life science entrepreneurs.

Timestamps:

00:00 Introduction and Guest Introductions

01:18 Origins of the Collaboration

02:28 Introducing GEMMA: The AI Model

05:31 Venture Creation Model

12:25 Human-AI Collaboration Benefits

14:50 Challenges and Future Potential

21:40 Scalability and Implementation

27:10 Future Plans and Closing Remarks

Resource & People Mentioned:

- Nordic BioVentures – http://www.nbv.bio

- Amass Technologies – https://www.amass.tech

- GEMMA – AI-driven scientific intelligence platform developed by Amass Technologies

- FEESH – Case study company leveraging AI CSO agents for accelerated biotech innovation

- Also a shoutout to the team and collaborators behind FEESH: Benjamin Aust, Josephine Schrøder Warming, Christian Code, our AI partners Henrik Jensen & Alexander Junge from amass, and the support from CPHLabs community.

Ideas for future podcast guests or themes? 💡

We want to co-create this podcast with you. We'd therefore love to hear your suggestions for future podcast guests or themes.

Feel free to share in a private message or leave a comment below 🙏🏼

(It's also ok to invite yourself 😉)

Join Our Life Science Talent Ecosystem

We want to build a community to inspire life science professionals and leaders through talent talks and organized events. Share knowledge across the life science community through personal stories of their journey.

We encourage you to take part in shaping this community by sharing your feedback, questions, or ideas. This you can do through our LinkedIn⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠community page⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠.

Warm Regards from your podcast hosts: ⁠⁠⁠⁠⁠⁠⁠⁠⁠Nehar Mortuza⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ and⁠⁠⁠ ⁠⁠⁠Søren Spanner Bach

In this episode Andy Boyce and Shane West  introduce "The Forge", Norway's first national biotechnology accelerator, set to launch in 2025.

They outline the structure and objectives of the six-month accelerator program, designed to support early-stage biotech researchers and startups in Norway.

The Forge aims to provide participants with critical knowledge, industry expertise, and expansive networking opportunities to help them advance toward successful commercialization.

Andrew and Shane also highlight the program's collaborative foundation, shared vision, and its unique nationwide scope, all crafted to foster innovation and drive commercial success in the biotech sector.

This episode is essential listening for anyone passionate about biotech innovation, entrepreneurship, and the startup ecosystem.

Timestamps:

00:08  Introduction: Overview of Norway's First National Biotech Accelerator

00:33 Guest Spotlight: Meet Andrew Boyce & Shane West

01:50 Target Audience: Who Should Join the Accelerator?

02:44 The Forge: Unpacking the Name, Mission, and Vision

04:39 Collaboration: The Partnership Between Digital Life Norway (DLN) and ALEAP

08:15 Key Takeaways: Program Benefits and Expected Outcomes for Participants

17:19 Applications: Process, Eligibility Criteria, and Key Considerations

18:17 Timeline: Program Schedule and Tips for a Successful Application

29:25 Future Focus: Supporting The Forge and the Growth of Biotech in Norway

30:22 Closing Reflections: Final Thoughts and Key Messages

The Forge Highlights:

- 6-month accelerator, including workshops, remote learning sessions, and expert mentorship.

- Specialized topics such as intellectual property, regulatory pathways, and market access.

- Meet fellow biotech startup founders, researchers, and industry experts.

- Connect with potential mentors, advisors, and partners in Norway’s biotech ecosystem.

- Access to tools, methods, and expertise to tackle commercialization challenges.

- Develop a roadmap for protecting intellectual property and accessing markets..

Resource Mentioned:

Apply to join The Forge accelerator

More about the accelerator programme

Digital Life Norway

Aleap

Ideas for future podcast guests or themes? 💡

We want to co-create this podcast with you. We'd therefore love to hear your suggestions for future podcast guests or themes.

Feel free to share in a private message or leave a comment below 🙏🏼

(It's also ok to invite yourself 😉)

Join Our Life Science Talent Ecosystem

We want to build a community to inspire life science professionals and leaders through talent talks and organized events. Share knowledge across the life science community through personal stories of their journey. We encourage you to take part in shaping this community by sharing your feedback, questions, or ideas. This you can do through our LinkedIn⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠community page⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠.

Warm Regards from your podcast hosts: ⁠⁠⁠⁠⁠⁠⁠⁠⁠Nehar Mortuza⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ and⁠⁠⁠ ⁠⁠⁠Søren Spanner Bach

In this episode, Jes Andersen, a visionary leader and driving force behind the Innovation District Copenhagen, shares his expertise and insights on the hub's remarkable development and success. With a unique blend of academic, industry, and startup collaboration, the district has emerged as a global innovation hotspot. Jes talks about the origins and growth of the Innovation District, highlighting the pivotal role of strategic partnerships, infrastructure projects, and targeted lobbying efforts.

Throughout the conversation, Jes emphasizes the importance of fostering a culture of collaboration, mutual respect, and open communication among diverse stakeholders. He discusses the district's evolution, from its humble beginnings to its current status as a thriving ecosystem, and shares valuable lessons learned along the way. Jes also reflects on his personal journey, revealing the passions and motivations that led him to spearhead this groundbreaking initiative.

As a seasoned expert, Jes offers actionable advice for professionals seeking to contribute to and benefit from Copenhagen's vibrant innovation landscape. He emphasizes the need for adaptability, creativity, and resilience in navigating the complex intersections of academia, industry, and entrepreneurship. Additionally, Jes highlights the district's commitment to talent development, diversity, and inclusion, ensuring a dynamic and sustainable innovation ecosystem.

Timestamps:

Introduction and Overview (00:00 - 03:50)

00:32 - Overview of the Innovation District

District Development (03:50 - 11:14)

03:50 - Rebranding and Development Strategies

08:29 - Fostering Collaborations and Partnerships

Ecosystem Support (11:14 - 21:03)

11:14 - Government Support and Advocacy Efforts

15:04 - Quantum Computing and Emerging Trends

16:52 - Startup Support and Impact Assessment

Vision and Leadership (21:03 - 34:32)

21:03 - Copenhagen's Attractiveness and Vision

31:25 - Jes Andersen's Personal Journey and Career Path

34:32 - Conclusion and Final Remarks

Ideas for future podcast guests or themes? 💡

We want to co-create this podcast with you. We'd therefore love to hear your suggestions for future podcast guests or themes.

Feel free to share in a private message or leave a comment below 🙏🏼

(It's also ok to invite yourself 😉)

Join Our Life Science Talent Ecosystem

We want to build a community to inspire life science professionals and leaders through talent talks and organized events. Share knowledge across the life science community through personal stories of their journey. We encourage you to take part in shaping this community by sharing your feedback, questions, or ideas. This you can do through our LinkedIn⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠community page⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠.

Warm Regards from your podcast hosts: ⁠⁠⁠⁠⁠⁠⁠⁠⁠Nehar Mortuza⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ and⁠⁠⁠ ⁠⁠⁠Søren Spanner Bach

Excited to share the latest episode featuring Line Holst Graves, CEO of Longest Straw, where she shares her inspiring journey from a corporate career to founding her own consultancy, which focuses on guiding biotech and planetary health founders through commercial expansion to secure high-value customers and strategic partnerships.

Line discusses the common challenges scientific entrepreneurs face when commercializing their innovations, offering actionable advice for accelerating market validation.

Key discussion points include the importance of building a strong commercial foundation, adopting a structured approach to client engagement, and leveraging external expertise to fuel business growth.

Timestamps:

00:47 Line's Background and Career Journey

01:45 Starting the Longest Straw

05:10 Challenges and Support in Entrepreneurship

10:07 Advice for Aspiring Entrepreneurs

18:44 Common Gaps in Scientific Startups

20:24 Bridging the Commercial Experience Gap

20:56 Balancing Multiple Roles as a Founder

22:17 The Importance of Market Validation

24:34 Structured Approach to Client Engagement

25:45 The Value of Commercial Leadership

28:16 Practical Tips for Accelerating Market Validation

36:30 Looking Ahead: Future Plans and Opportunities

39:55 Final Advice for Founders

Resource Mentioned:

Line's email: line@longestdraw.com

Ideas for future podcast guests or themes? 💡

We want to co-create this podcast with you. We'd therefore love to hear your suggestions for future podcast guests or themes.

Feel free to share in a private message or leave a comment below 🙏🏼

(It's also ok to invite yourself 😉)

Join Our Life Science Talent Ecosystem

We want to build a community to inspire life science professionals and leaders through talent talks and organized events. Share knowledge across the life science community through personal stories of their journey. We encourage you to take part in shaping this community by sharing your feedback, questions, or ideas. This you can do through our LinkedIn⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠community page⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠.

Warm Regards from your podcast hosts: ⁠⁠⁠⁠⁠⁠⁠⁠⁠Nehar Mortuza⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ and⁠⁠⁠ ⁠⁠⁠Søren Spanner Bach

In the latest episode of Life Science Talent Talks, our host sits down with Jan Dideriksen, CEO and Founder of Nordic Virtual Pastures, to explore the company's fascinating journey.

Jan shares how his team has navigated pivotal shifts in strategy and embraced an innovative approach by utilizing fractional hires to extend runway and optimize progress.

A key focus of the discussion is Nordic Virtual Pastures' unique use of sustainably sourced cell media products from bio-waste streams to support cellular agriculture, cultivated meat, and mammalian cell growth.

Jan shares insights on the importance of customer feedback, the company's strategic pivots and the role of fractional hires such as CCO Line Holst Graves in achieving milestones more efficiently.

The conversation provides practical tips for startups on navigating pivots, engaging with investors, and leveraging fractional talent to achieve business goals.

For startup leaders, investors, and innovators, this conversation is packed with actionable advice on managing pivots, engaging with investors, and building lean yet highly effective teams.

Timestamps:

01:05 Overview of Nordic Virtual Pastures

01:12 Product Details and Technology

03:11 Market and Competitive Advantage

05:44 Journey to Entrepreneurship

07:25 First Pivot: From Cell Growth to Cultivated Meat

10:15 Second Pivot: Focusing on Media Components

13:20 Current Strategy and Market Fit

16:32 Feedback and Adaptation

20:43 Innovative Strategies for Product Market Fit

21:03 The Role of a Chief Commercial Officer

22:45 Importance of Customer Feedback

25:26 Fractional Hiring: A Strategic Approach

25:50 Building and Evolving the Team

32:58 Challenges and Benefits of Fractional Hiring

38:44 Future Plans and How to Support

39:50 Final Thoughts and Invitation to Connect

Ideas for future podcast guests or themes? 💡

We want to co-create this podcast with you. We'd therefore love to hear your suggestions for future podcast guests or themes.

Feel free to share in a private message or leave a comment below 🙏🏼

(It's also ok to invite yourself 😉)

Join Our Life Science Talent Ecosystem

We want to build a community to inspire life science professionals and leaders through talent talks and organized events. Share knowledge across the life science community through personal stories of their journey. We encourage you to take part in shaping this community by sharing your feedback, questions, or ideas. This you can do through our LinkedIn⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠community page⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠.

Warm Regards from your podcast hosts: ⁠⁠⁠⁠⁠⁠⁠⁠⁠Nehar Mortuza⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ and⁠⁠⁠ ⁠⁠⁠Søren Spanner Bach

In this insightful discussion, Cecilie Willer, whos executive coach specializing and founder mental health expert, shares her journey and professional expertise. The conversation dives into the psychological challenges faced by startup founders, including emotional regulation, identity fusion with their work, and active recovery. 

Cecilie provides practical tools and techniques for founders to manage stress, enhance self-awareness, and maintain a sustainable work-life balance. She emphasizes the importance of mental health in building successful and sustainable companies. She also discusses her upcoming book, "Built Without Burnout" which offers concrete tools and insights for founders and investors to support mental health in the startup world.

Timestamps:

02:06 Cecilia's Journey to Focusing on Founders' Mental Health

05:54 The Importance of Mental Health for Founders

07:25 Writing 'Built Without Burnout'

08:43 Challenges and Solutions for Founders' Mental Health

14:49 Self-Awareness and Emotional Regulation

25:00 Balancing Life and Startup Demands

29:11 Balancing Personal Life and Startup Growth

29:48 The Importance of Recovery for Founders

30:38 The Science Behind Burnout and Recovery

31:18 Implementing a Four-Day Work Week

32:22 Practicing Presence and Mindfulness

36:49 Dealing with Feelings of Inadequacy

44:48 Practical Tools for Self-Compassion

49:02 Conclusion and Resources

Ideas for future podcast guests or themes? 💡

We want to co-create this podcast with you. We'd therefore love to hear your suggestions for future podcast guests or themes.

Feel free to share in a private message or leave a comment below 🙏🏼

(It's also ok to invite yourself 😉)

Join Our Life Science Talent Ecosystem

We want to build a community to inspire life science professionals and leaders through talent talks and organized events. Share knowledge across the life science community through personal stories of their journey. We encourage you to take part in shaping this community by sharing your feedback, questions, or ideas. This you can do through our LinkedIn⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠community page⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠.

Warm Regards from your podcast hosts: ⁠⁠⁠⁠⁠⁠⁠⁠⁠Nehar Mortuza⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ and⁠⁠⁠ ⁠⁠⁠Søren Spanner Bach

Resource Mentioned In the episode:

• Changetoday.io

• Founder Tools
  

In this episode, Jacob Heckscher Sorensen, Director of Scientific Sales and Imaging Innovation at Gubra. Gubra, a biotech firm, specializes in clinical contract research organization services and proprietary drug discovery programs. Jacob delves into his career trajectory, from his educational background in developmental biology at Roskilde University and the University of Edinburgh to his groundbreaking work at Novo Nordisk and the Broad Institute. He shares insights on the development and application of quantitative 3D imaging and spatial biology in preclinical drug development. Jacob discusses the challenges and innovations in imaging, including the use of AI, automating microscopy processes, and the importance of building a virtual brain map for studying diseases like obesity, Alzheimer's, and Parkinson's. The conversation highlights the evolving technology's potential impact on future pharmaceutical and biotech research, emphasizing the synergy between scientific passion and business development in advancing the field.

Timestamps:

00:51 Jacob's Academic Journey and Early Career

02:27 Transition to Novo Nordisk and Imaging Innovations

04:10 Current Role at Gubra and Imaging Applications

06:34 Innovative Applications in Quantitative 3D Imaging

08:48 Challenges and Future Directions in Imaging

12:00 The Role of Imaging in Preclinical Drug Development

12:30 Transition from Science to Sales

13:42 Daily Activities and Collaborations

16:37 Future of Neuroscience and Imaging

18:40 Challenges in the Life Science Industry

26:55 Final Thoughts and Advice for Young Scientists

Ideas for future podcast guests or themes? 💡

We want to co-create this podcast with you. We'd therefore love to hear your suggestions for future podcast guests or themes.

Feel free to share in a private message or leave a comment below 🙏🏼

(It's also ok to invite yourself 😉)

Join Our Life Science Talent Ecosystem

We want to build a community to inspire life science professionals and leaders through talent talks and organized events. Share knowledge across the life science community through personal stories of their journey. We encourage you to take part in shaping this community by sharing your feedback, questions, or ideas. This you can do through our LinkedIn⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠community page⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠.

Warm Regards from your podcast hosts: ⁠⁠⁠⁠⁠⁠⁠⁠⁠Nehar Mortuza⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ and⁠⁠⁠ ⁠⁠⁠Søren Spanner Bach

Resource Mentioned In the episode:

Novo Nordisk Foundation

Bioinnovation Institute (BII) Venture Lab & Venture House

University of Copenhagen

https://www.triptobio.com

In this episode of Life Science Talent Talks, host Nehar Mortuza sits down with Rahmad Akbar, Senior Data Scientist in Antibody Design at Novo Nordisk. Rahmad shares his remarkable journey from his roots in Indonesia to his pivotal role at the forefront of machine learning-driven protein engineering. Together, they explore how AI is revolutionising antibody design — from the technical advances and current challenges to the growing role of generative models in creating next-generation therapeutics. Rahmad offers insights into how these technologies are accelerating drug discovery, improving patient outcomes, and shaping the future of healthcare. He also speaks candidly about his transition from academia to industry, the personal motivations that fuel his work, and why collaboration and innovation are more essential than ever in the life sciences. Whether you're passionate about biotech, data science, or career development, this episode is packed with valuable perspectives you won't want to miss.

Timestamp and Show notes:

00:38 Meet Our Special Guest: Rahmad Akbar

02:19 Rahmad's Journey: From Indonesia to Novo Nordisk

03:35 The Role of Coding in Biotechnology

04:45 Antibody Design: Challenges and Innovations

06:48 Generative AI in Drug Design

10:04 Future Trends and Democratizing AI

19:00 Personal Motivations and Career Reflections

24:31 Transitioning from Academia to Industry

29:47 Final Thoughts and Takeaways

Ideas for future podcast guests or themes? 💡

We want to co-create this podcast with you. We'd therefore love to hear your suggestions for future podcast guests or themes.

Join Our Life Science Talent Ecosystem

We want to build a community to inspire life science professionals and leaders through talent talks and organised events. Share knowledge across the life science community through personal stories of their journey. We encourage you to take part in shaping this community by sharing your feedback, questions, or ideas. This you can do through our LinkedIn⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠community page⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠.
Warm Regards from your podcast hosts: ⁠⁠⁠⁠⁠⁠⁠⁠⁠Nehar Mortuza⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ and⁠⁠⁠ ⁠⁠⁠Søren Spanner Bach

In this episode of Life Science Talent Talks, we sit down with Line Kloster Pedersen, CEO and founder of  Visibuilt. Line shares the inspiring story behind Visibuilt’s founding — from the spark of an idea during a run to securing funding and building a lab. She also dives into the challenges of scaling from 0 to 10 employees and how her team is working toward transforming the global asphalt industry.

Looking ahead, Visibuilt is targeting a soft launch in 2026, with a fully commercial product by 2028. This episode is packed with insights for entrepreneurs, including funding strategies, the importance of timing, and the realities of scaling a life sciences startup.

This episode is packed with valuable insights for entrepreneurs, including how to navigate funding challenges, the importance of timing in startups, and the realities of scaling a life sciences company. Whether you're an aspiring founder or a seasoned entrepreneur, Line's story offers inspiration and practical takeaways.

Timestamps:

00:05:09 - The Dirty Process of Asphalt Production

00:05:20 - Visibit's Innovative Solution

00:05:57 - Early Prototypes and Laboratory Phase

00:08:09 - Securing Early Funding and Building a Lab

00:10:26 - First Funding Successes

00:11:24 - Growth and Hiring the First Employees

00:12:35 - Building the Team and Securing Patents

00:16:07 - Future Goals and Commercialization Timeline

00:20:59 - Transitioning from Solo Founder to Team Leader

00:24:04 - Balancing Collective Perspective and Speed

00:25:08 - Deciding on Personal vs. Delegated Tasks

00:26:10 - One-on-One Meetings and Their Benefits

00:28:09 - Avoiding Problems Through Regular Check-ins

00:29:48 - Organizational Leadership Challenges

00:34:08 - Team Building Activities

00:36:25 - Hiring Strategies and Learnings

00:38:10 - Balancing Hires and Consultants

00:41:35 - Facility and Location Importance

00:43:11 - Most Rewarding Aspects of the Journey

Ideas for future podcast guests or themes? 💡

We want to co-create this podcast with you. We'd therefore love to hear your suggestions for future podcast guests or themes.

Feel free to share in a private message or leave a comment below 🙏🏼

(It's also ok to invite yourself 😉)

Join Our Life Science Talent Ecosystem

We want to build a community to inspire life science professionals and leaders through talent talks and organized events. Share knowledge across the life science community through personal stories of their journey. We encourage you to take part in shaping this community by sharing your feedback, questions, or ideas. This you can do through our LinkedIn⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠community page⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠.

Warm Regards from your podcast hosts: 

Nehar Mortuza and Søren Spanner Bach

In this special edition of Life Science Talent Talks, Søren brings listeners an exclusive preview of TechBBQ 2024, with a focus on the Life Science Without Borders stage. They spotlight four innovative startups set to pitch groundbreaking ideas in planetary and human health. Joining them is Jan Thordsen, the organizer of the TechBBQ life science track, who shares insights into the event's growth, the importance of life science in the tech world, and what attendees can expect.

TechBBQ 2024 promises to be an exciting and transformative event for the life science and technology sectors, with a special focus on innovation, startups, and the intersection of healthcare and technology. This year, the event will showcase cutting-edge advancements in life science, providing a platform for startups, entrepreneurs, investors, and industry experts to connect, collaborate, and explore new opportunities.

The event will feature a diverse range of speakers, including thought leaders, successful entrepreneurs, and industry pioneers who will share their insights, experiences, and strategies for navigating the rapidly evolving landscape of life sciences. Attendees will have the opportunity to engage in thought-provoking discussions, attend workshops, and participate in networking sessions designed to foster collaboration and inspire new ideas.

Whether you're an entrepreneur looking to launch your startup, an investor seeking the next big opportunity, or a professional interested in the latest trends in life science innovation, TechBBQ 2024 is an event you won't want to miss.

Timestamps:

02:56 What is TechBBQ Life Science Track?: Jan gives an overview of TechBBQ

04:54 Target Audience for the Life Science Track: The types of startups that can benefit from the life science track at TechBBQ 

07:04 The top reasons why startups should participate in TechBBQ

08:45 Integration of AI and machine learning in life science, highlighting the relevance of these areas in the current TechBBQ context.

09:12 The theme for TechBBQ 2024, “One Giant Leap,” and the improvements made from last year, including a more structured approach to the life science track.

11:00 Discussion about the life science stage, the increase in speakers from last year, and the focus on delivering valuable content from the stage

12:17 Various ways attendees can engage at TechBBQ, 

13:00 A new feature for this year, the Nordic Life Science Investor Dinner, designed to foster connections between startups and investors.

14:31 Success stories from startups that participated in previous TechBBQ events

Resource Mentioned: 

Media Overview for TechBBQ 2023.

Media Overview for TechBBQ 2022

Ideas for future podcast guests or themes? 💡

We want to co-create this podcast with you. We'd therefore love to hear your suggestions for future podcast guests or themes.

Feel free to share in a private message or leave a comment below 🙏🏼

(It's also ok to invite yourself 😉)

Join Our Life Science Talent Ecosystem

We want to build a community to inspire life science professionals and leaders through talent talks and organized events. Share knowledge across the life science community through personal stories of their journey. We encourage you to take part in shaping this community by sharing your feedback, questions, or ideas. This you can do through our LinkedIn⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠community page⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠.

Warm Regards from your podcast hosts: ⁠⁠⁠⁠⁠⁠⁠⁠⁠Nehar Mortuza⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ and⁠⁠⁠ ⁠⁠⁠Søren Spanner Bach

In this special edition of Life Science Talent Talks, Nehar features Line Petersen, the founder of Bellyfood, a pioneering startup that creates real food blends for individuals with feeding tubes. Line shares the inspiring story behind Bellyfood, which began when her son Otto, who required a feeding tube, started experiencing severe issues with traditional tube feeding formulas. Motivated by a desire to improve her son's health, Line embarked on a journey of extensive research and kitchen experimentation, eventually developing nutritious, real-food alternatives that transformed Otto's well-being.

Line discusses Bellyfood’s evolution from a personal project to a growing startup, detailing the challenges of product development, gaining regulatory approval, and scaling the business. Now a key player in the Danish market, Bellyfood is looking to expand into other European markets. The episode also highlights Bellyfood’s participation in TechBBQ 2024, where they aim to network with industry professionals and raise awareness about the importance of real food in tube feeding. Listeners are encouraged to follow Bellyfood on social media to support their mission and stay updated on their progress.

Timestamps:

01:15 Line shares her background and the story behind Bellyfood

02:38 Success story: How Otto's condition improved dramatically with Bellyfood's real food blends.

04:00 Product Development and Challenges

05:00 Scaling and Market Expansion

06:00 Comparison with major competitors like Nestlé and Danone.

08:00 Participation in Tech Barbecue 2024

08:24 How Listeners Can Support Bellyfood

Ideas for future podcast guests or themes? 💡

We want to co-create this podcast with you. We'd therefore love to hear your suggestions for future podcast guests or themes.

Feel free to share in a private message or leave a comment below 🙏🏼

(It's also ok to invite yourself 😉)

Join Our Life Science Talent Ecosystem

We want to build a community to inspire life science professionals and leaders through talent talks and organized events. Share knowledge across the life science community through personal stories of their journey. We encourage you to take part in shaping this community by sharing your feedback, questions, or ideas. This you can do through our LinkedIn⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠community page⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠.
Warm Regards from your podcast hosts: ⁠⁠⁠⁠⁠⁠⁠⁠⁠Nehar Mortuza⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ and⁠⁠⁠ ⁠⁠⁠Søren Spanner Bach

In this special edition of Life Science Talent Talks, Nehar sat down with Mads Terndrup, the founder of Exo360, a groundbreaking startup focused on transforming non-surgical treatment options for fractures. This episode is part of a collaboration with TechBBQ 2024, where Exo360 will pitch on the Life Science Without Borders stage.

Mads shares his journey from a promising career in orthopedic surgery to founding Exo360, a company that aims to replace outdated plaster casting methods with innovative, standardized solutions using metamaterials. The discussion covers the challenges of merging clinical expertise with entrepreneurial ambition, the development of their first product—the XO360 wrist—and their plans to address diabetic foot ulcers.

Timestamps:

01:14 Meet Mads, founder of Exo360

01:57 The Problem Exo360 is Solving

03:00 The transition from an orthopedic surgeon to an entrepreneur.

03:53 Mads persuaded Michael, a branding and marketing expert, to join Exo360

04:48 Exo360’s First Product

06:48 Discussion on the challenges of developing a medical device.

09:00 Launching a new funding round to accelerate the development of a solution for diabetic foot ulcers.

Ideas for future podcast guests or themes? 💡

We want to co-create this podcast with you. We'd therefore love to hear your suggestions for future podcast guests or themes.

Feel free to share in a private message or leave a comment below 🙏🏼

(It's also ok to invite yourself 😉)

Join Our Life Science Talent Ecosystem

We want to build a community to inspire life science professionals and leaders through talent talks and organized events. Share knowledge across the life science community through personal stories of their journey. We encourage you to take part in shaping this community by sharing your feedback, questions, or ideas. This you can do through our LinkedIn⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠community page⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠.

Warm Regards from your podcast hosts: ⁠⁠⁠⁠⁠⁠⁠⁠⁠Nehar Mortuza⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ and⁠⁠⁠ ⁠⁠⁠Søren Spanner Bach

In this episode, Peter Holme, the CEO of Cambiotics, discusses his new startup, a spinoff from the University of Cambridge aimed at detoxifying the human body from harmful PFAS chemicals using precision probiotics. Peter shares his extensive background as a scientist and entrepreneur, including his journey with Aquapoint and his involvement in innovation in Denmark. He explains the science behind Cambiotics, the current stage of the company, and the challenges they face in transitioning from lab and animal studies to human clinical trials. Peter highlights their plan to introduce the product to the U.S. market by partnering with the American Firefighter Associations, who are at high risk of PFAS exposure. He also discusses the company's participation in TechBBQ and emphasizes the critical need for global awareness about PFAS pollution.

Timestamps:

00:00 Introduction to Peter Holme and Cambiotics

01:58 Overview of Cambiotics

02:34 Technology Behind Cambiotics

03:21 Current Stage and Future Plans

04:02 Challenges and Clinical Trials

06:56 Participation in Tech Barbecue

08:07 Raising Awareness About PFAS

09:58 Conclusion and Final Thoughts

Ideas for future podcast guests or themes? 💡

We want to co-create this podcast with you. We'd therefore love to hear your suggestions for future podcast guests or themes.

Feel free to share in a private message or leave a comment below 🙏🏼

(It's also ok to invite yourself 😉)

Join Our Life Science Talent Ecosystem

We want to build a community to inspire life science professionals and leaders through talent talks and organized events. Share knowledge across the life science community through personal stories of their journey. We encourage you to take part in shaping this community by sharing your feedback, questions, or ideas. This you can do through our LinkedIn⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠community page⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠.

Warm Regards from your podcast hosts: ⁠⁠⁠⁠⁠⁠⁠⁠⁠Nehar Mortuza⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ and⁠⁠⁠ ⁠⁠⁠Søren Spanner Bach

In this episode, Shannon and Kathryn, co-founders of Reefcircular, discuss their innovative startup that develops environmentally friendly bioconcrete made from waste shells, which is 3D printed into artificial reefs. They share their backgrounds in marine science and architecture, recount the serendipitous way they met, and describe their research and development phase, including their first pilot project in Denmark. They highlight the need for boosting biodiversity and fish stocks in temperate climates, their unique reef designs, and the challenges of funding and market awareness. They also talk about their participation in TechBBQ 2024 and invite collaborations to further their mission.

Timestamps:

00:00 Meet the Founders: Shannon and Kathryn

01:49 The Birth of Reefcircular

01:56 Innovative Bioconcrete and 3D Printing

02:33 A Chance Meeting on Facebook

03:10 Current Stage and Pilot Projects

03:55 First Deployment Success

04:28 Designing and Installing Boulder Reefs

05:42 Boosting Biodiversity and Fish Stocks

07:41 Challenges and Market Potential

09:10 Tech Barbecue 2024 Participation

10:05 Call to Action and Future Collaborations

Ideas for future podcast guests or themes? 💡

We want to co-create this podcast with you. We'd therefore love to hear your suggestions for future podcast guests or themes.

Feel free to share in a private message or leave a comment below 🙏🏼

(It's also ok to invite yourself 😉)

Join Our Life Science Talent Ecosystem

We want to build a community to inspire life science professionals and leaders through talent talks and organized events. Share knowledge across the life science community through personal stories of their journey. We encourage you to take part in shaping this community by sharing your feedback, questions, or ideas. This you can do through our LinkedIn⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠community page⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠.

Warm Regards from your podcast hosts: ⁠⁠⁠⁠⁠⁠⁠⁠⁠Nehar Mortuza⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ and⁠⁠⁠ ⁠⁠⁠Søren Spanner Bach

In this episode Johan Andersen-Ranberg, CSO and co-founder of TriptoBIO, shares his journey from academic research to entrepreneurship. 

Johan discusses how his work with the plant Tripterygium wilfordii led to the development of a novel, cost-effective solution for producing Triptolite and it’s commercial application prevention of rat infestations.

The conversation delves into various aspects of Johan’s entrepreneurial path, including hiring strategies, securing funding, and transitioning from academia to a startup environment.

Johan also offers advice for aspiring life science entrepreneurs, emphasizing the importance of finding the right co-founder and engaging with potential customers early on.

Timestamps:

00:38 Diving Deep into Biotech Innovations with Johan

01:01 The Genesis of TriptoBio: From PhD Project to Biotech Breakthrough

02:06 Revolutionizing Rodent Control: A Safer, Sustainable Solution

06:11 Navigating the Path to Entrepreneurship: Johan's Journey & The Evolution of TriptoBio

11:30 Building a Business: Funding, Collaboration, and Growth

13:36 The Power of Partnership: Co-Founding and Scaling Up

15:49 The Founding Team's Journey

16:23 The Pivotal Hire and Its Impact

17:13 Progress Towards Product Registration

18:09 Challenges and Strategies of Being a First-Time Founder

18:28 Hiring Strategies in a Startup

26:17 Future Prospects and Product Launch Timeline

27:10 Entrepreneurship: Personal Reflections and Advice

Ideas for future podcast guests or themes? 💡

We want to co-create this podcast with you. We'd therefore love to hear your suggestions for future podcast guests or themes.

Feel free to share in a private message or leave a comment below 🙏🏼

(It's also ok to invite yourself 😉)

Join Our Life Science Talent Ecosystem

We want to build a community to inspire life science professionals and leaders through talent talks and organized events. Share knowledge across the life science community through personal stories of their journey. We encourage you to take part in shaping this community by sharing your feedback, questions, or ideas. This you can do through our LinkedIn⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠community page⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠.

Warm Regards from your podcast hosts: ⁠⁠⁠⁠⁠⁠⁠⁠⁠Nehar Mortuza⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ and⁠⁠⁠ ⁠⁠⁠Søren Spanner Bach

Resource Mentioned In the episode:

Novo Nordisk Foundation

Bioinnovation Institute (BII) Venture Lab & Venture House

University of Copenhagen

https://www.triptobio.com/

In this episode, we feature an in-depth conversation with Randi Wahlsten, CEO of MATR Foods, based in Copenhagen. The discussion explores Randi's transition from a corporate career at McKinsey and Arla Foods to leading a food startup focused on creating plant-based food alternatives. 

In the episode we discuss MATR Foods' innovative use of fermentation, the challenges of scaling production, and the importance of creating craveable, locally sourced products without additives. 

The episode also highlights the startup's approach to product development, the necessity of diverse skills in the team, and the journey from concept to market. 

Randi shares valuable advice for food startups on navigating the complexities of in-house production and the significance of early prototyping and feedback from key stakeholders of the food exusystem.

Learn about the vision, strategy, and future ambitions of MATR Foods as they work towards making a significant impact on global food consumption patterns.

Timestamps:

00:38 Introducing MATR Foods with CEO Randi Wahlsten

02:02 The Vision and Technology Behind MATR Foods

04:56 Randi Wahlsten's Journey from Corporate to Startup

13:52 Challenges and Strategies in Scaling Production

26:41 Approach to Product Development and Customer Feedback

36:28 Future Aspirations and Advice for Food Science Startups

39:55 Closing Thoughts and Call to Action

Ideas for future podcast guests or themes? 💡

We want to co-create this podcast with you. We'd therefore love to hear your suggestions for future podcast guests or themes.

Feel free to share in a private message or leave a comment below 🙏🏼

(It's also ok to invite yourself 😉)

Join Our Life Science Talent Ecosystem

We want to build a community to inspire life science professionals and leaders through talent talks and organized events. Share knowledge across the life science community through personal stories of their journey. We encourage you to take part in shaping this community by sharing your feedback, questions, or ideas. This you can do through our LinkedIn⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠community page⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠.

Warm Regards from your podcast hosts: ⁠⁠⁠⁠⁠⁠⁠⁠⁠Nehar Mortuza⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ and⁠⁠⁠ ⁠⁠⁠Søren Spanner Bach

Resource mentioned In the episode:

• McKinsey
• Arla Foods
• Homepage: Matrfoods.com
• Linkedin: https://www.linkedin.com/company/matrfoods/
• instagram: @matrfds
• BII or the BioInnovation Institute (Venture Lab & Venture House program)
• Myers canteens collaborated with MATR Foods
• Nemlig.com - as a private individual, you should go buy it at Nemlig
• Klaus Wittrupf, who owns The Gasoline Grill - MATR is now available to order as the vegetarian option in any burger at all Gasoline Grill (See link HERE)

In today’s episode of Life Science Talent Talks, Søren dive into the fascinating journey of EvodiaBio, a bio-industrial startup focused on producing sustainable aroma compounds for non-alcoholic beers and beyond. Co-founders Camilla and Victor and discuss the founding and scaling of EvodiaBio, located west of Copenhagen.  The episode covers various topics, including the company's innovative technology for producing monoterpenes through yeast cell fermentation, challenges in setting up production in-house, and the company's mission to revolutionize industries by offering environmentally sustainable flavor solutions. They also talk about the importance of having a diverse team, the startup's culture, and future aspirations for expanding into other industries. The long-term aspiration is being able to supply the market with aroma for everything … and that journey starts with Yops™ Timestamps: 00:46 Introducing EvodiaBio: A Startup Journey 02:53 The Science Behind EvodiaBio's Aroma Molecules 04:40 From Technology to Product: The EvodiaBio Approach 09:43 The Early Days and Evolution of EvodiaBio 15:54 Building a Team and Scaling Up 22:02 The Challenges of Setting Up Production In-House 26:03 Startup Culture and Hiring Practices 27:03 The Exciting Journey to Global Launch 27:36 Innovating with Customized Blends for Breweries 28:27 Tech Deep Dive: Evolving Technology and Production Challenges 33:45 Leadership Insights: Building a Diverse and Effective Team 36:14 Scaling Up: Structuring for Growth and Maintaining Culture 43:15 Future Aspirations and Closing Advice Ideas for future podcast guests or themes? 💡 We want to co-create this podcast with you. We'd therefore love to hear your suggestions for future podcast guests or themes. Feel free to share in a private message or leave a comment below 🙏🏼 (It's also ok to invite yourself 😉) Join Our Life Science Talent Ecosystem We want to build a community to inspire life science professionals and leaders through talent talks and organized events. Share knowledge across the life science community through personal stories of their journey. We encourage you to take part in shaping this community by sharing your feedback, questions, or ideas. This you can do through our LinkedIn⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠community page⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠. Warm Regards from your podcast hosts: ⁠⁠⁠⁠⁠⁠⁠⁠⁠Nehar Mortuza⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ and⁠⁠⁠ ⁠⁠⁠Søren Spanner Bach Resource Mentioned In the Pod: University of Copenhagen Bioinnovation Institute Technical University of Denmark Danish Technological Institute LinkedIn Instagram

In this episode of Life Science Talent Talks introduces BioBridge Partners, a consultancy group focused on life sciences, co-founded by Daniel Schmidt. Daniel shares his transition from a business background, with an education from Copenhagen Business School and a career start at Monitor Deloitte, to a meaningful venture in life sciences strategy consulting. Despite the challenge of commercialising life science innovations, Daniel and his colleague, driven by passion for impactful work, founded BioBridge Partners after Deloitte declined their proposal for a life science-focused team. 

The company aims to be a trusted advisor across the life science spectrum, aiding biotech's, pharma companies, and investors to navigate complex situations and drive value from their investments. Schmidt discusses the challenges the industry faces, such as increasing drug development costs against smaller patient populations, and emphasises the importance of strategic consulting within this evolving ecosystem. The talk ends with an invitation to life science professionals to explore the intersection of science and strategy, underlining the ongoing innovation and potential within the Nordic life science community.

Timestamps:

00:40 A Deep Dive with Daniel Schmidt: From Consulting to Life Science Innovation

01:17 The Genesis of BioBridge Partners

05:56 Navigating the Leap: From Deloitte to Startup Success

08:28 BioBridge Partners: Bridging Gaps in the Life Science Ecosystem

08:32 The Growth and Impact of BioBridge Partners

14:50 The Future Vision and Challenges of Life Science

16:13 Challenges and Opportunities in the Life Science Industry

17:52 Advice for Aspiring Life Science Strategy Consultants

𝗜𝗱𝗲𝗮𝘀 𝗳𝗼𝗿 𝗳𝘂𝘁𝘂𝗿𝗲 𝗽𝗼𝗱𝗰𝗮𝘀𝘁 𝗴𝘂𝗲𝘀𝘁𝘀 𝗼𝗿 𝗽𝗼𝗱𝗰𝗮𝘀𝘁 𝘁𝗵𝗲𝗺𝗲𝘀? 💡

We want to co-create this podcast with you. We'd therefore love to hear your suggestions for future podcast guests or themes.

Feel free to share in a private message or leave a comment below 🙏🏼

(It's also ok to invite yourself 😉)

𝗝𝗼𝗶𝗻 𝗢𝘂𝗿 𝗟𝗶𝗳𝗲 𝗦𝗰𝗶𝗲𝗻𝗰𝗲 𝗧𝗮𝗹𝗲𝗻𝘁 𝗘𝗰𝗼𝘀𝘆𝘀𝘁𝗲𝗺:

We want to build a community to inspire life science professionals and leaders through talent talks and organised events. Share knowledge across the life science community through personal stories of their journey. We encourage you to take part in shaping this community by sharing your feedback, questions, or ideas. This you can do through our LinkedIn⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠community page⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠.

Warm Regards from your podcast hosts: ⁠⁠⁠⁠⁠⁠⁠⁠⁠Nehar Mortuza⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ and⁠⁠⁠ ⁠⁠⁠Søren Spanner Bach

In this episode, we take you inside the story of Mmimetika, a biotech venture co-founded by researchers Mogens Johannsen and Thomas Poulsen. What began as a bold university lab project has grown into a breakthrough company developing a compound that mimics some of the key health benefits of exercise and fasting.

By combining ketones and lactate in a single, novel molecule, Mmimetika's lactate | ketone non-medicinal supplement provides promising support for metabolic control and longevity.

We dive into their journey from academic discovery to commercial reality — securing patents, scaling production, attracting investors, and building a business team around their scientific vision.

Now on the cusp of regulatory approval, Mmimetika is actively searching for a dynamic CEO to lead the charge into market launch and long-term growth.

Whether you're curious about biotech entrepreneurship, metabolic health innovations, or how groundbreaking research turns into real-world solutions, this is a story you won’t want to miss.

Shownotes and Timestamps

[00:00:00] Company Introduction  

[00:01:12] Mimicking Exercise and Fasting  

[00:04:08] Current Status and Journey  

[00:05:54] Product Superiority and Development  

[00:08:13] Competition and IP  

[00:10:18] Funding and Investor Relations  

[00:11:17] Technical Aspects of the Product  

[00:13:00] Clinical Evidence and Scientific Approach  

[00:14:22] Non-Medical Claims

[00:15:29] Market Focus and Positioning  

[00:17:58] Roadmap and Milestones  

[00:21:22] Organizational Structure and Key Risks  

[00:23:00] CEO Transition and Future Roles  

[00:25:04] Company Culture and CEO Profile  

[00:27:26] Soft Skills and Ideal Timing for CEO  

[00:29:42] How Listeners Can Support  

Ideas for future podcast guests or themes? 💡

We want to co-create this podcast with you. We'd therefore love to hear your suggestions for future podcast guests or themes.

Feel free to share in a private message or leave a comment below 🙏🏼

(It's also ok to invite yourself 😉)

Join Our Life Science Talent Ecosystem

We want to build a community to inspire life science professionals and leaders through talent talks and organized events. Share knowledge across the life science community through personal stories of their journey. We encourage you to take part in shaping this community by sharing your feedback, questions, or ideas. This you can do through our LinkedIn⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠community page⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠.

Warm Regards from your podcast hosts: ⁠⁠⁠⁠⁠⁠⁠⁠⁠Nehar Mortuza⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ and⁠⁠⁠ ⁠⁠⁠Søren Spanner Bach

This episode of Life Science Talent Talks features the story behind Tempty Foods, a startup dedicated to innovating the future of plant-based food products.

The podcast explores the journey of Tempty Foods' founding team, focusing on leveraging team diversity and their lean innovation model. The team includes Co-Founders Ana Pejic, Cecilie Engvang Lund, and Martina Lokajova, who share their backgrounds, the company's mission, and the challenges they faced in launching new innovative products in the food industry. 

Join us in celebrating Tempty Foods' journey and learn how this diverse team has worked with talent and personality tests to build trust and leverage team diversity.

Timestamps:

00:39 Introducing Tempty Foods: A Journey of Innovation and Diversity

05:08 The Founders' Personal Journeys and the Birth of Tempty Foods

08:00 From Idea to Reality: Developing a Novel Food Product

14:38 Navigating Challenges and Scaling Up Production

18:42 Breaking into the Food Service Industry: A Strategic Pivot

22:43 Future Plans and Reflections on the Entrepreneurial Journey

26:27 A Fortuitous Partnership with Quorn

27:38 Innovating in the Food Industry Without a Factory

28:52 Creating the Foods of the Future: A Focus on Sustainability and Flexibility

32:43 The Lean Startup Model: Navigating Production and Market Challenges

39:42 Building a Strong Team Through Understanding Diversity

51:26 Looking Ahead: Sales, Expansion, and Community Engagement

𝗜𝗱𝗲𝗮𝘀 𝗳𝗼𝗿 𝗳𝘂𝘁𝘂𝗿𝗲 𝗽𝗼𝗱𝗰𝗮𝘀𝘁 𝗴𝘂𝗲𝘀𝘁𝘀 𝗼𝗿 𝗽𝗼𝗱𝗰𝗮𝘀𝘁 𝘁𝗵𝗲𝗺𝗲𝘀? 💡

We want to co-create this podcast with you. We'd therefore love to hear your suggestions for future podcast guests or themes.

Feel free to share in a private message or leave a comment below 🙏🏼

(It's also ok to invite yourself 😉)

𝗝𝗼𝗶𝗻 𝗢𝘂𝗿 𝗟𝗶𝗳𝗲 𝗦𝗰𝗶𝗲𝗻𝗰𝗲 𝗧𝗮𝗹𝗲𝗻𝘁 𝗘𝗰𝗼𝘀𝘆𝘀𝘁𝗲𝗺:

We want to build a community to inspire life science professionals and leaders through talent talks and organized events. Share knowledge across the life science community through personal stories of their journey. We encourage you to take part in shaping this community by sharing your feedback, questions, or ideas. This you can do through our LinkedIn⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠community page⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠.

Warm Regards from your podcast hosts: ⁠⁠⁠⁠⁠⁠⁠⁠⁠Nehar Mortuza⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ and⁠⁠⁠ ⁠⁠⁠Søren Spanner Bach

In this episode, Christian from DTU Science Park introduces a new MedTech Accelerator Program called MedTech Growth. This new accelerator aims to support MedTech startups at various stages, offering tailored advice and guidance on overcoming industry-specific challenges such as regulatory affairs, quality management, market access, and financing. Throughout the episode, Christian takes us through the specifics of the program.

Applications are open for Danish startups (including those from southern Sweden) and the deadline is 21 May 2024, however, Christian encourages startups to get in touch to learn more about the requirements.

Feel free to reach out to Christian in case you have questions: cha@dtusciencepark.dk or +45 31349522

Timestamps:

00:38 Introducing Christian and the MedTech Growth Accelerator

01:46 Deep Dive into the MedTech Growth Accelerator Program

02:47 Challenges and Solutions for MedTech Startups

04:37 Investor Matchmaking and Funding Strategies

09:16 Program Specifics: Bootcamp and Sprint Phases

12:07 Eligibility and Application Process for Startups

22:46 Engaging with Experts and Mentors

27:13 Closing Remarks and Call to Action

𝗜𝗱𝗲𝗮𝘀 𝗳𝗼𝗿 𝗳𝘂𝘁𝘂𝗿𝗲 𝗽𝗼𝗱𝗰𝗮𝘀𝘁 𝗴𝘂𝗲𝘀𝘁𝘀 𝗼𝗿 𝗽𝗼𝗱𝗰𝗮𝘀𝘁 𝘁𝗵𝗲𝗺𝗲𝘀? 💡

We want to co-create this podcast with you. We'd therefore love to hear your suggestions for future podcast guests or themes.

Feel free to share in a private message or leave a comment below 🙏🏼

(It's also ok to invite yourself 😉)

𝗝𝗼𝗶𝗻 𝗢𝘂𝗿 𝗟𝗶𝗳𝗲 𝗦𝗰𝗶𝗲𝗻𝗰𝗲 𝗧𝗮𝗹𝗲𝗻𝘁 𝗘𝗰𝗼𝘀𝘆𝘀𝘁𝗲𝗺:

We want to build a community to inspire life science professionals and leaders through talent talks and organized events. Share knowledge across the life science community through personal stories of their journey. We encourage you to take part in shaping this community by sharing your feedback, questions, or ideas. This you can do through our LinkedIn⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠community page⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠.

Warm Regards from your podcast hosts: ⁠⁠⁠⁠⁠⁠⁠⁠⁠Nehar Mortuza⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ and⁠⁠⁠ ⁠⁠⁠Søren Spanner Bach

In this episode, Martin Stenfeldt, an experienced life science entrepreneur, shares his journey from working in corporate life sciences to co-founding MeTrace Pharma and his transition to mentoring startups. 

The discussion explores Martin's book project in the making called "Scaling Life-Science Startups" where Martin is creating a catalog of best practices from successful startup scaling journeys in life science.

The book is based on Martin's own experiences and peer interviews with over 35+ professionals in the industry (so far).

During this conversation, we dive more into Martin's approach of converting peer-interview into actionable insights, scaling challenges, commercialization complexities, and the importance of building a company culture from the start.

Special attention is given to the practical aspects of managing growth, such as adopting a results-focused approach, and the importance of bringing experienced industry professionals into management teams early on in the journey.

The conversation also touches on various strategies for entering the U.S. market, the significance of setting achievable goals, and the necessity of regular strategic review and KPI monitoring. 

This episode offers valuable insights into the life science industry, specifically tailored towards entrepreneurs, board members, investors, and those interested in startup to scale-up transitions in the life science space.

Timestamps:

00:38 Introducing Martin Stenfeldt: A Life Science Entrepreneur's Journey

02:24 The Genesis of a Life Science Scale-Up Book Project

06:25 Target Audience and Scope of the Book

08:13 Defining Scale-Ups and Interview Insights

10:31 Developing the Expert Model for Scaling Startups

13:06 Personal Learnings and Best Practices for Scaling

15:58 Cultural Dynamics and Leadership Transitions in Scaling

20:45 The Founder's Dilemma: When to Step Down

23:26 Exploring Leadership and Company Culture

24:02 The Importance of Core Values in Shaping Culture

28:31 Attracting and Retaining Talent with a Strong Culture

32:12 Life Science Scale-Up Challenges: Commercialization and Market Access

36:08 Incorporating Experience and Regulatory Insight into Management

41:41 Achieving Results and Strategic Focus for Scale-Ups

44:58 Anticipating the Book Release: Process and Expectations

𝗕𝗲𝗰𝗼𝗺𝗲 𝗽𝗮𝗿𝘁 𝗼𝗳 𝘁𝗵𝗲 𝗟𝗶𝗳𝗲 𝗦𝗰𝗶𝗲𝗻𝗰𝗲 𝗧𝗮𝗹𝗲𝗻𝘁 𝗘𝗰𝗼𝘀𝘆𝘀𝘁𝗲𝗺:

We want to build a community to inspire life science professionals and leaders through talent talks and organized events. Share knowledge across the life science community through personal stories of their journey. We encourage you to take part in shaping this community by sharing your feedback, questions, or ideas. This you can do through our LinkedIn⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠community page⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠.

𝗚𝗲𝘁 𝗶𝗻 𝘁𝗼𝘂𝗰𝗵!

We would love to hear your thoughts and ideas. Please share your feedback or ideas for future themes or guests with us on LinkedIn.

Warm Regards from your podcast hosts:⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠Nehar Mortuza⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ and⁠⁠⁠⁠ ⁠⁠⁠Søren Spanner Bach

Today's episode of Life Science Talent Talks features a deep dive into the integration and impact of generative AI in life sciences, with insights from Samuel Demharter, a Senior Data Scientist at Genmab, and Henrik Jensen, CEO & co-founder at amass, an AI startup focusing on supercharging R&D productivity.

They explore their personal journeys into the AI field, highlighting the blend of scientific and commercial expertise driving innovation in life sciences. The discussion spans challenges and opportunities in adopting generative AI within pharma and biotech, emphasizing the need for strategic management and internal expertise. The conversation also touches on challenges like hallucination in AI outputs and the importance of human oversight.

Looking ahead, they speculate on the future of drug development and the role of AI, advocating for a cautious yet proactive approach to integrating new technologies. 

The episode concludes with practical advice for individuals looking to enter the field, emphasizing the importance of interdisciplinary learning and experimentation in the future integrated with AI technologies.

Timestamps:

00:40 Diving Into Generative AI in Life Science R&D

00:59 Introducing the Experts: Diverse Backgrounds in Life Sciences

05:41 The Inspirations Behind Choosing AI and Computational Paths

10:25 Exploring the Integration of AI in Pharma and Biotech

12:01 The Challenges of AI Adoption in the Pharma Industry

30:50 Future Perspectives: The Evolution of AI in Life Sciences

33:49 Practical Advice for Embracing AI in Life Sciences

39:31 Closing Thoughts and Encouragement

𝗕𝗲𝗰𝗼𝗺𝗲 𝗽𝗮𝗿𝘁 𝗼𝗳 𝘁𝗵𝗲 𝗟𝗶𝗳𝗲 𝗦𝗰𝗶𝗲𝗻𝗰𝗲 𝗧𝗮𝗹𝗲𝗻𝘁 𝗘𝗰𝗼𝘀𝘆𝘀𝘁𝗲𝗺:

We want to build a community to inspire life science professionals and leaders through talent talks and organized events. Share knowledge across the life science community through personal stories of their journey. We encourage you to take part in shaping this community by sharing your feedback, questions, or ideas. This you can do through our LinkedIn⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠community page⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠.

𝗚𝗲𝘁 𝗶𝗻 𝘁𝗼𝘂𝗰𝗵 𝗯𝘆 𝘃𝗼𝗶𝗰𝗲𝗺𝗮𝗶𝗹 𝗼𝗿 𝗟𝗶𝗻𝗸𝗲𝗱𝗜𝗻:

Please share your feedback or ideas for future themes or guests with us on LinkedIn.

Warm Regards from your podcast hosts: ⁠⁠⁠⁠⁠⁠⁠⁠⁠Nehar Mortuza⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ and⁠⁠⁠ ⁠⁠⁠Søren Spanner Bach

In this episode, we had the pleasure of hosting the co-founders of FÆRM, Andrea and Mikkel.

Their story is nothing short of a rollercoaster ride filled with passion, innovation, and sheer determination spiced up with a couple of "near-death experiences.

Andrea, with her background in food technology, and Mikkel, with his expertise in commercial law and business administration, shared their unique journey of creating FÆRM. They've taken the challenge of transforming the plant-based cheese industry by applying traditional dairy methods to plant proteins, resulting in a product that's not only delicious but also sustainable.

Their startup story is a testament to the power of a strong partnership and a shared vision. Despite facing near-bankruptcy multiple times, they've managed to navigate through the tumultuous waters of entrepreneurship with grace and grit. Their commitment to maintaining a fun, positive, and supportive work culture has been a cornerstone of their success.

As they look to the future, FÆRM is on the brink of commercial breakthroughs, with exciting research and potential partnerships on the horizon. 

Tune in to learn how FÆRM is revolutionizing the world of plant-based cheese with their unique approach!

About FÆRM

We are FÆRM, a food tech company that uses science to further traditional cheese production methods, creating the future of non-dairy products. We re-design plant-masses to achieve the well-known textures and flavors from cheese to create taste experiences - unlike anything you’ve had before.

Timestamps:

00:01:10 - FÆRM'S Founders' Backgrounds

00:01:55 - FÆRM'S Mission and Plant-Based Cheese

00:02:44 - Environmental Impact of Cheese

00:02:58 - FÆRM'S Unique Business Model

00:03:54 - Founders' Inspiration to Start FÆRM'S

00:04:17 - The Early Days and Vision of FÆRM'S

00:08:37 - The Journey Begins: From Idea to Action

00:09:08 - The Transition from Cashew to Bean-Based Cheese

00:10:21 - The InnoFounder Grant and a New Direction

00:11:04 - Building a Company Culture and Identity

00:13:18 - The Dark Year of 2022 and Financial Struggles

00:15:10 - The Turning Point: A Business Angel Steps In

00:16:06 - The Investor Landscape and Challenges

00:18:18 - The Science Behind FÆRM'S Cheese

00:21:31 - The GreenUp Accelerator and Prototyping

00:23:16 - The Second Bankruptcy Scare and Investor Relations

00:25:37 - The Business Model Pivot and Licensing Strategy

00:27:07 - The Importance of a Strong Founder Relationship

00:29:21 - The Team's Dedication and Work Culture

00:31:10 - The Future of FÆRM'S and Commercialization Plans

00:33:01 - Seeking New Team Members and Partnerships

00:34:03 - The Founders' Dynamic and Shared Vision

𝗕𝗲𝗰𝗼𝗺𝗲 𝗽𝗮𝗿𝘁 𝗼𝗳 𝘁𝗵𝗲 𝗟𝗶𝗳𝗲 𝗦𝗰𝗶𝗲𝗻𝗰𝗲 𝗧𝗮𝗹𝗲𝗻𝘁 𝗘𝗰𝗼𝘀𝘆𝘀𝘁𝗲𝗺:

We want to build a community to inspire life science professionals and leaders through talent talks and organized events. Share knowledge across the life science community through personal stories of their journey. We encourage you to take part in shaping this community by sharing your feedback, questions, or ideas. This you can do through our LinkedIn⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠community page⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠.

𝗚𝗲𝘁 𝗶𝗻 𝘁𝗼𝘂𝗰𝗵 𝗯𝘆 𝘃𝗼𝗶𝗰𝗲𝗺𝗮𝗶𝗹 𝗼𝗿 𝗟𝗶𝗻𝗸𝗲𝗱𝗜𝗻:

Feel free to share feedback or ideas for future themes or guests using our voicemail you can access⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠⁠here⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠: (no voicemails will be published without your explicit approval).

Warm Regards from your podcast hosts: ⁠⁠⁠⁠⁠⁠⁠⁠⁠Nehar Mortuza⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ and⁠⁠⁠ ⁠⁠⁠Søren Spanner Bach

In this engaging conversation, hosted at Symbion before a REBBLS event, venture capitalists Stephan Christgau and Jeppe Tranekær share valuable insights into what captivates investors and secrets behind successful venture pitches.

Stephan, with his rich background in life sciences, sheds light on his journey from academia to biotech, eventually diving into the venture capital world with Novo Holdings and later founding Eir Ventures, a life science venture fund.

Jeppe, holding a business and climate solutions background, discusses his venture into the venture capital scene with Look Up Ventures, focusing on deep tech and bio-solutions. 

The duo emphasizes key components for startups approaching VCs, like having a strong, committed team, a scalable, transformative product addressing an unmet need, and presenting clear, concise, and well-researched pitches. In this episode they discuss the importance of understanding team dynamics, obtaining warm introductions, and ensuring that key elements such as comparison data and the commitment level of founders are addressed in pitches.

About REBBLS

REBBLS stands for Rising Entrepreneurs in BioBusiness and Life Science. We are a network connecting the Danish biotech and life science community with a focus on entrepreneurship, personal development and creating meaningful business relationships.

REBBLS'​ purpose is to improve the success of intrapreneurs and increase the volume and quality of life science startups. We attempt to contribute to a higher success rate of these ventures and activities by being actively committed to our mission of connecting talents within life science entrepreneurship and provide tools that enable them to be successful in the industry.

Timestamps:

01:12 Meet the Speakers: Stephan's Journey

03:33 Meet the Speakers: Jeppe's Journey

06:03 Key Factors for Investment Opportunities

08:28 The Importance of Team Dynamics

12:53 The Do's and Don'ts When Approaching Investors

18:34 The Role of the Management Team in Startups

20:55 The Importance of Transparency and Trust

26:08 Presenting the Team in a Pitch Deck

28:18 Final Thoughts and Advice

𝗕𝗲𝗰𝗼𝗺𝗲 𝗽𝗮𝗿𝘁 𝗼𝗳 𝘁𝗵𝗲 𝗟𝗶𝗳𝗲 𝗦𝗰𝗶𝗲𝗻𝗰𝗲 𝗧𝗮𝗹𝗲𝗻𝘁 𝗘𝗰𝗼𝘀𝘆𝘀𝘁𝗲𝗺:

We want to build a community to inspire life science professionals and leaders through talent talks and organized events. Share knowledge across the life science community through personal stories of their journey. We encourage you to take part in shaping this community by sharing your feedback, questions, or ideas. This you can do through our LinkedIn⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠community page⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠.

𝗚𝗲𝘁 𝗶𝗻 𝘁𝗼𝘂𝗰𝗵 𝗯𝘆 𝘃𝗼𝗶𝗰𝗲𝗺𝗮𝗶𝗹 𝗼𝗿 𝗟𝗶𝗻𝗸𝗲𝗱𝗜𝗻:

Feel free to share feedback or ideas for future themes or guests using our voicemail you can access⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠⁠here⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠: (no voicemails will be published without your explicit approval).
Warm Regards from your podcast hosts: ⁠⁠⁠⁠⁠⁠⁠⁠⁠Nehar Mortuza⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ and⁠⁠⁠ ⁠⁠⁠Søren Spanner Bach

This podcast is a conversation with Paula Petcu, a serial entrepreneur, co-founder at TETATET, former CTO of Brainplus and a leader at Lundbeck . She walks us through her career journey and her current role, which involves wearing several hats including pitching to investors and undertaking software development work. At TETATET, she shares about the development of an emotionally aware AI coach, which uses a smartphone's microphone and camera to gauge user's emotions, creating empathetic conversation. The initiative is designed to support therapists and life coaches and their clients. Paula talks about her entrance into podcasting with a focus on founders mental health within the healthcare domain. Paula shares insight into her leadership style, identifying with 'conscious leadership', and how it has fostered transparency, empathy and self-awareness within her teams. She also shares her experiences as a female leader within the tech space and her involvement with Women CTO Dinners. She is also a host of her podcast ‘ Founders mental Health - Do You Walk the Talk’

SHOWNOTES

00:39 Introduction and Guest Background

01:10 Paula's Journey to Entrepreneurship

02:05 Exploring TETATET: An Emotional Aware AI Coach

03:18 Target Audience and Application of TETATET

05:12 Interactive Features of TETATET

09:11 Paola's Podcasting Venture: Founders, Mental Health

10:26 Paola's Experience at Lundbeck

13:49 Transition to Entrepreneurship

16:17 Understanding Conscious Leadership

27:28 Challenges and Criticisms of Conscious Leadership

32:51 Women in Tech and Conscious Leadership

35:15 Walking the Talk: Personal Growth and Reflection

In this podcast episode, Stephanie Holstein-Rønsbo and Ditte Boilesen, first-time founders behind the biotech startup, Loma Therapeutics.

During the episode these two talented women unfold their entrepreneurial journey, they highlight their combined expertise in biomedical and life science as well as their transition into entrepreneurship, their decision-making processes, the importance of having a structured, prioritized approach, and their commitment to fostering a safe, supportive team culture. 

They discuss their future plans, including maturing their case, defining their product, setting their clinical strategy, and expanding their team. 

This podcast is an invaluable resource for anyone interested in the world of startups and the biotech industry!

About Loma Therapeutics

Human Papilloma virus (HPV) causes cellular changes that can ultimately lead to cancer and affects many people in Denmark and globally. Loma Therapeutics offers a novel immunotherapy against HPV, which has the potential to treat all HPV patients and outperform competing immunotherapies in development.

Timestamps:

00:00 Background of the Founders

05:19 The Journey to Founding Loma Therapeutics

15:12 Challenges and Surprises in the Founding Process

19:08 The Dynamics of the Founding Team

22:45 Implementing a Structured Approach to Team Meetings

23:26 The Importance of Understanding Team Dynamics

24:31 Building Trust and Equality in the Team

25:14 Envisioning the Culture of Loma

27:11 Challenges and Learnings as Founders

28:28 The Importance of Seeking Expertise

33:51 Looking Ahead: The Future of Loma Therapeutics

36:20 Advice for First-Time Founders

𝗕𝗲𝗰𝗼𝗺𝗲 𝗽𝗮𝗿𝘁 𝗼𝗳 𝘁𝗵𝗲 𝗟𝗶𝗳𝗲 𝗦𝗰𝗶𝗲𝗻𝗰𝗲 𝗧𝗮𝗹𝗲𝗻𝘁 𝗘𝗰𝗼𝘀𝘆𝘀𝘁𝗲𝗺:

We want to build a community to inspire life science professionals and leaders through talent talks and organized events. Share knowledge across the life science community through personal stories of their journey. We encourage you to take part in shaping this community by sharing your feedback, questions, or ideas. This you can do through our LinkedIn⁠⁠⁠⁠⁠⁠⁠ ⁠⁠community page⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠.

𝗚𝗲𝘁 𝗶𝗻 𝘁𝗼𝘂𝗰𝗵 𝗯𝘆 𝘃𝗼𝗶𝗰𝗲𝗺𝗮𝗶𝗹 𝗼𝗿 𝗟𝗶𝗻𝗸𝗲𝗱𝗜𝗻:

Feel free to share feedback or ideas for future themes or guests using our voicemail you can access⁠⁠⁠ ⁠⁠⁠⁠⁠⁠⁠here⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠: (no voicemails will be published without your explicit approval).

Warm Regards from your podcast hosts:
⁠⁠⁠⁠⁠⁠⁠⁠Nehar Mortuza⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ and⁠⁠ ⁠⁠⁠Søren Spanner Bach

In this candid and insightful podcast episode Scott Quainoo, the co-founder & CEO of Unveil Bio, shares his intriguing journey of transition from being a scientist to an entrepreneur. 

Scott explains the importance of shifting from traditional approaches to doing things differently, bringing value to scientists with Unveil Bio's state-of-the-art sequencing services. 

In addition, Scott sheds light on the concept of following one's own path, not being afraid to ask or offer help, and the significance of creating a healthy work culture.

He encourages aspiring entrepreneurs, scientists, and listeners to connect, share ideas, stories, and extend their network for mutual growth and learning.

About Unveil Bio

Historically, DNA sequence validation has relied heavily on antiquated, time-tested methods. But as the boundaries of science expand, innovative and more powerful techniques are emerging to challenge and redefine these norms. Unveil Bio is at the forefront of this revolution, offering the scientific community our cutting-edge whole plasmid sequencing service. From our base in Copenhagen, we serve a vast array of researchers throughout Europe. Our service is more than just sequencing; it's a commitment to unparalleled quality, advanced Nanopore technology, swift delivery times, and pioneering bioinformatics. Supporting scientists from academic institutions, hospitals, and global pharmaceutical and biotechnology companies, we see ourselves as an integral part of your research team, enabling you to discover the unknown.

Timestamps:

03:39 The Journey to Entrepreneurship

07:03 The Inception of Unveil Bio

11:06 Challenges and Growth of Unveil Bio

13:35 Transitioning to Full-Time Entrepreneurship

19:32 Reflections on the Entrepreneurial Journey

22:43 Overcoming Challenges and Embracing Openness

23:12 The Importance of Seeking Advice and Collaboration

24:39 The Journey of Defining a Mission for Unveil Bio

26:07 The Power of Customer Feedback and Building a Purpose

27:32 The Role of Knowledge Sources and Mentors in the Entrepreneurial Journey

30:40 Building a Healthy and Sustainable Organizational Culture

34:55 Actionable Tips for Aspiring Entrepreneurs

39:08 Looking Ahead: The Future of Unveil Bio

𝗕𝗲𝗰𝗼𝗺𝗲 𝗽𝗮𝗿𝘁 𝗼𝗳 𝘁𝗵𝗲 𝗟𝗶𝗳𝗲 𝗦𝗰𝗶𝗲𝗻𝗰𝗲 𝗧𝗮𝗹𝗲𝗻𝘁 𝗘𝗰𝗼𝘀𝘆𝘀𝘁𝗲𝗺:

We want to build a community to inspire life science professionals and leaders through talent talks and organized events. Share knowledge across the life science community through personal stories of their journey. We encourage you to take part in shaping this community by sharing your feedback, questions, or ideas. This you can do through our LinkedIn⁠⁠⁠⁠⁠⁠ ⁠⁠community page⁠⁠⁠⁠⁠⁠⁠⁠⁠.

𝗚𝗲𝘁 𝗶𝗻 𝘁𝗼𝘂𝗰𝗵 𝗯𝘆 𝘃𝗼𝗶𝗰𝗲𝗺𝗮𝗶𝗹 𝗼𝗿 𝗟𝗶𝗻𝗸𝗲𝗱𝗜𝗻:

Feel free to share feedback or ideas for future themes or guests using our voicemail you can access⁠⁠ ⁠⁠⁠⁠⁠⁠⁠here⁠⁠⁠⁠⁠⁠⁠⁠⁠: (no voicemails will be published without your explicit approval).

Warm Regards from your podcast hosts:

⁠⁠⁠⁠⁠⁠⁠Nehar Mortuza⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ and⁠ ⁠⁠⁠Søren Spanner Bach⁠⁠⁠⁠⁠⁠⁠

In this episode Sandra Wingaard Thrane, the co-founder and CSO, and Sebastian Søderberg, the CEO of Bactolife, share insights into the company's journey from early days at DTU and their experience of scaling it + and a bit about their Binding Proteins™ technology.

The conversation dives into their backgrounds and how their complementary skills have enabled Bactolife to move forward successfully.

They discuss the challenges involved in innovating and bringing new technology to the market, the value of having a transparent culture, and the necessity of being resilient.

Looking ahead, Sandra and Sebastian share their plans about entering partnerships with food ingredient, consumer health, and supplement companies, and eagerly anticipate the opportunity to spread awareness about their technology and projects.

About Bactolife

We are on a mission to enhance global gut health and support the fight against antimicrobial resistance. As a Danish biotech firm, we're pioneering the future of gut health with our unique ingredients, Binding Proteins. These breakthrough Binding Protein ingredients, natural and versatile enough for any food, beverage, or supplement, selectively bind and block harmful microbial activity without disturbing the beneficial microbiome — a truly revolutionary approach. Our products are specially formulated for diverse needs, benefiting everyone from mothers and children to the elderly, immune-compromised individuals, travelers, and even animals. Backed by investors such as Novo Holdings, the Bill & Melinda Gates Foundation, and Innovation Fund Denmark, we are committed to making Binding Proteins widely available. Our vision is a future where these proteins are a common part of diets, supporting gut health globally. Our deep understanding of Binding Proteins, combined with competitive pricing, enables us to make these innovations accessible. Join us as we change the future of gut health one Binding Protein at a time.

Timestamp & Shownotes

01:15 The Founding Story of Bactolife 

02:51 The Mission and Vision of Bactolife

03:51 The Journey of Bactolife: From Inception to Success

06:17 The Challenges and Triumphs of Building a Biotech Startup

07:18 The Role of Funding and Investment in Bactolife’s Growth

08:15 The Impact of Bactolife’s Technology and Products

10:11 The Future of Bactolife and Its Market Potential

14:23 Reflections on the Highs and Lows of the Bactolife Journey

20:45 The Power of Teamwork and Collaboration in Bactolife’s Success

24:31 Complementing Each Other

24:50 The Role of Temper in Passion

26:05 Building a C Suite and Collaboration

27:32 Nurturing a Transparent Culture

29:55 The Importance of Trust and Psychological Safety

30:39 Maintaining Transparency in a Growing Company

35:38 Challenges and Learnings in Scaling the Company

47:08 Looking Ahead: Future Plans for Bactolife

𝗕𝗲𝗰𝗼𝗺𝗲 𝗽𝗮𝗿𝘁 𝗼𝗳 𝘁𝗵𝗲 𝗟𝗶𝗳𝗲 𝗦𝗰𝗶𝗲𝗻𝗰𝗲 𝗧𝗮𝗹𝗲𝗻𝘁 𝗘𝗰𝗼𝘀𝘆𝘀𝘁𝗲𝗺:

We want to build a community to inspire life science professionals and leaders through talent talks and organized events. Share knowledge across the life science community through personal stories of their journey. We encourage you to take part in shaping this community by sharing your feedback, questions, or ideas. This you can do through our LinkedIn⁠⁠⁠⁠⁠⁠ ⁠community page⁠⁠⁠⁠⁠⁠⁠⁠.

𝗚𝗲𝘁 𝗶𝗻 𝘁𝗼𝘂𝗰𝗵 𝗯𝘆 𝘃𝗼𝗶𝗰𝗲𝗺𝗮𝗶𝗹 𝗼𝗿 𝗟𝗶𝗻𝗸𝗲𝗱𝗜𝗻:

Feel free to share feedback or ideas for future themes or guests using our voicemail you can access⁠ ⁠⁠⁠⁠⁠⁠⁠here⁠⁠⁠⁠⁠⁠⁠⁠: (no voicemails will be published without your explicit approval).

Warm Regards from your podcast hosts:

⁠⁠⁠⁠⁠⁠Nehar Mortuza⁠⁠⁠⁠⁠⁠⁠⁠⁠ and ⁠⁠⁠Søren Spanner Bach⁠⁠⁠⁠⁠⁠⁠

In this episode, we sit down with Janine Erler, CEO, and Lluís Riera Ponsati, Program Lead at NEUmiRNA Therapeutics to discuss their groundbreaking work in developing disease-modifying RNA therapies for neurological disorders.

From their startup journey to the intricate science behind their therapies, the conversation spans key milestones, technology challenges, and the unique patient-focused culture at Neumirna.

Janine and Lluís share insights on their successful fundraising, the impact of their microRNA-based approach, and the practical aspects of going from academic research to clinical applications.

They also discuss the organizational dynamics, collaborations, and future aspirations of the company, making this a compelling listen for any life sciences professional interested in the transformative potential of RNA therapies.

Show notes & Timestamp

00:43 Introducing Neumirna Therapeutics

02:10 Founding Story of Neumirna

03:29 Key Milestones and Team Growth

06:50 Challenges and Collaborations

15:23 Technology Behind Neumirna's RNA Therapies

23:19 Focus on Neurological Diseases

24:57 Exploring the Potential of ASO Technology

25:26 The Future of RNA Therapies

27:44 Navigating Regulatory Challenges

28:37 Team and Culture at Neumirna

35:23 Hiring and Onboarding at Neumirna

37:36 Proud Moments and Achievements

43:02 Immediate Priorities and Challenges

44:43 Connecting with the Community

45:51 Conclusion and Final Thoughts

Ideas for future podcast guests or themes? 💡

We want to co-create this podcast with you. We'd therefore love to hear your suggestions for future podcast guests or themes.

Feel free to share in a private message or leave a comment below 🙏🏼

(It's also ok to invite yourself 😉)

Join Our Life Science Talent Ecosystem

We want to build a community to inspire life science professionals and leaders through talent talks and organized events. Share knowledge across the life science community through personal stories of their journey. We encourage you to take part in shaping this community by sharing your feedback, questions, or ideas. This you can do through our LinkedIn⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠community page⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠.

Warm Regards from your podcast hosts: ⁠⁠⁠⁠⁠⁠⁠⁠⁠Nehar Mortuza⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ and⁠⁠⁠ ⁠⁠⁠Søren Spanner Bach

In this conversation, Professor Londa Schiebinger, a professor of History of Science at Stanford University and the Director of Gendered Innovation in Science, Health, and Medicine, Engineering, and Environmental Projects, shares her insights about the intersection between science, gender, and innovation. Drawing from her career spanning several decades, Professor Scheibinger discusses her journey into this field, moving from undergraduate studies in English Literature to a career in history. She delves into the concept of gendered innovations and its relevance in scientific progress, providing an in-depth discussion about the difference between sex and gender and its consideration in research. Notable examples from healthcare, life sciences, engineering, including AI and social robots, were analyzed. Professor Scheibinger also speaks about her role in reshaping research funding and international policies, particularly within the European Commission and her hope for a future where gender and intersectional analysis are integrated into all research.   SHOWNOTES 00:00 Introduction and Guest Presentation 00:48 Professor Scheibinger's Journey to Gendered Innovations 02:40 Exploring the Intersection of History and Gender 02:57 Unveiling the Story of Plants and Empires 05:56 Understanding the Role of Women in History 07:50 The Evolution of Birthing Practices 08:55 Introducing the Concept of Gendered Innovations 11:22 The Impact of Gendered Innovations in Various Fields 19:49 The Role of Gender in Robotics 25:25 Promoting Diversity and Gender Equity in Innovation and Leadership 36:46 The Future of Gendered Innovations

In this discussion, Nicolas Krink, the CEO and co-founder of BioHalo, shares in detail his experience transitioning from research and academia to entrepreneurship.

BioHalo is a biotech startup aiming to replace PFAS, with safer, more sustainable alternatives.

The talk elaborates on the company's inception, the dynamics among the co-founders, and the challenges faced so far.

Nico stresses the importance of a cohesively working team and the value of continuous learning in an ever-evolving startup environment.

For those interested, BioHalo is actively seeking collaborations, expertise in PFAS regulations, funding, and resources to support their mission.

About BioHalo

BioHalo are at the forefront of revolutionizing the halogenated chemicals industry. With their cutting-edge biofluorination technology, they offer a greener and more sustainable alternative to conventional fluorochemistry practices. Our primary mission is to develop bio-based materials that serve as safe and eco-friendly replacements for harmful PFAS forever chemicals in various industrial formulations without compromising on performance.

At BioHalo, they are committed to driving positive change in the chemicals industry by promoting environmental consciousness and responsible manufacturing. They firmly believe that environmental responsibility goes hand in hand with innovation, and this core belief drives them forward.

Timestamp & Shownotes

00:38 Introduction and Background of the CEO

01:31 The Journey to Becoming a CEO

02:44 The Birth of BioHalo

02:57 The Mission and Vision of BioHalo

05:36 The Impact of PFAS on Modern Society

06:41 The Entrepreneurial Journey

08:14 The Process of Establishing BioHalo

14:17 The Importance of Teamwork in a Startup

22:39 The Importance of Communication and Understanding in a Team

23:57 The Role of the BII (BioInnovation Institute) Program and Reflections on the Journey

25:44 Building a Company Culture and Vision

27:13 Challenges and Surprises in the Entrepreneurial Journey

28:30 The Mindset Shift from Academia to Entrepreneurship

31:40 Looking Ahead: Scaling and Growing the Business

32:38 Reflections and Advice for Aspiring Entrepreneurs

37:41 Call to Action: How Listeners Can Help

𝗕𝗲𝗰𝗼𝗺𝗲 𝗽𝗮𝗿𝘁 𝗼𝗳 𝘁𝗵𝗲 𝗟𝗶𝗳𝗲 𝗦𝗰𝗶𝗲𝗻𝗰𝗲 𝗧𝗮𝗹𝗲𝗻𝘁 𝗘𝗰𝗼𝘀𝘆𝘀𝘁𝗲𝗺:

We want to build a community to inspire life science professionals and leaders through talent talks and organized events. Share knowledge across the life science community through personal stories of their journey. We encourage you to take part in shaping this community by sharing your feedback, questions, or ideas. This you can do through our LinkedIn⁠⁠⁠⁠⁠ ⁠community page⁠⁠⁠⁠⁠⁠⁠.

𝗚𝗲𝘁 𝗶𝗻 𝘁𝗼𝘂𝗰𝗵 𝗯𝘆 𝘃𝗼𝗶𝗰𝗲𝗺𝗮𝗶𝗹 𝗼𝗿 𝗟𝗶𝗻𝗸𝗲𝗱𝗜𝗻:

Feel free to share your thoughts and your feedback using our voicemail you can access⁠ ⁠⁠⁠⁠⁠⁠here⁠⁠⁠⁠⁠⁠⁠: (no voicemails will be published without your explicit approval).

Warm Regards from your podcast hosts:

⁠⁠⁠⁠⁠Nehar Mortuza⁠⁠⁠⁠⁠⁠⁠⁠ and ⁠⁠Søren Spanner Bach⁠⁠⁠⁠⁠⁠

Episode was recorded 18 December 2023.

In this podcast, Hans Schambye, the CEO of Galacto and board member of Dansk Biotech, discusses his journey in biotechnology.  Hans shares his experiences, from founding Galecto as a university spin-out to elevating it to a NASDAQ listed company.  As an MD PhD and his passion for the pharmaceutical industry he emphasises the importance of team work and coming up with solutions collectively.  Hans highlights the need for diversity in teams and adapting to varying cultures in different countries.  The interview explores his leadership style, which is defined by open and transparent communication; his role in Dansk Biotech and his fight to change taxation policies on future incomes.  Finally, Hans discusses the significant role biotech will play in solving problems related to human health and the environment in future, encouraging more young people to join the industry.

This series is sponsored by PharmaDanmark

Shownotes

00:51 Introduction and Guest Presentation

01:10 Journey to Founding Galecto

01:55 Career Path and Transition into the Pharmaceutical Industry

03:27 First Leadership Role and Learning Curve

00:00 The Role of a Leader and Importance of Teamwork

05:18 Role in Dansk Biotech and Political Influence

08:27 Leading Teams Across Different Countries

15:17 Promoting Diversity, Equity, and Inclusion

17:58 Lessons Learned and Leadership Growth

20:37 Closing Remarks and Take Home Message

In this conversation, angel investor Nicolaj Højer Nielsen discusses his transition from entrepreneur to angel investor, the characteristics he values in a startup team, and the importance of founders understanding their market and its complexities, particularly in the life science industry.

He emphasizes the importance of diversity in the founding team and the need for at least one member to possess the skills and passion to sell the product or idea, even before it's brought to market.

Discussing his investment criteria, Nicolaj considers it crucial for founders to have worked on multiple projects over time for them to understand the challenges and complexities of their startup journey.

He also stresses the importance of networking and having a clear understanding of the market landscape and demands.

Nicolaj’s perspective provides valuable insights for founders and investors alike.

Timestamp & Shownotes

00:37 Introduction and Background of Nicolaj

01:19 Nicolaj's Journey from Entrepreneur to Investor

04:10 Investing in Life Science Companies

06:42 When is it a Good Case for a Life Science Company to Take in a Business Angel

08:24 The Importance of Team Dynamics in Startups

08:57 What to Look for in a Startup Team

11:06 Red Flags in Startup Teams

13:30 The Role of Diversity in Startup Teams

22:58 The Importance of Understanding the Ecosystem in Life Science Startups

29:42 The Impact of Life Science Companies

This interview was done in connection with an "Ventures and Wine Café" on 14 December 2023, a free monthly F2F networking event organized by REBBLS (Rising Entrepreneurs in BioBusiness and Life Science).

Follow REBBLS on Eventbrite to get notified by upcoming events here

𝗕𝗲𝗰𝗼𝗺𝗲 𝗽𝗮𝗿𝘁 𝗼𝗳 𝘁𝗵𝗲 𝗟𝗶𝗳𝗲 𝗦𝗰𝗶𝗲𝗻𝗰𝗲 𝗧𝗮𝗹𝗲𝗻𝘁 𝗘𝗰𝗼𝘀𝘆𝘀𝘁𝗲𝗺:

We want to build a community to inspire life science professionals and leaders through talent talks and organized events. Share knowledge across the life science community through personal stories of their journey. We encourage you to take part in shaping this community by sharing your feedback, questions, or ideas. This you can do through our LinkedIn⁠⁠⁠⁠⁠⁠ ⁠community page⁠⁠⁠⁠⁠⁠⁠⁠.

𝗚𝗲𝘁 𝗶𝗻 𝘁𝗼𝘂𝗰𝗵 𝗯𝘆 𝘃𝗼𝗶𝗰𝗲𝗺𝗮𝗶𝗹 𝗼𝗿 𝗟𝗶𝗻𝗸𝗲𝗱𝗜𝗻:

Feel free to share your thoughts and your feedback using our voicemail you can access⁠ ⁠⁠⁠⁠⁠⁠⁠here⁠⁠⁠⁠⁠⁠⁠⁠: (no voicemails will be published without your explicit approval).

Warm regards from your podcast hosts:

⁠⁠⁠⁠⁠⁠Nehar Mortuza⁠⁠⁠⁠⁠⁠⁠⁠⁠ and ⁠⁠⁠Søren Spanner Bach⁠⁠⁠⁠⁠⁠

In this episode Gerit Tolborg shared the exciting story about her journey of co-founding Chromologics, a biotech startup, which started as her PhD project at the Technical University of Denmark.

After working on a fascinating red molecule, she discovered a novel way of producing natural food colors through fermentation.

She and her co-founder Anders (Ødum) Odum raised funds, built a team and started the company and moved out from the University. Gerit shares some of the challenges they faced, including fundraising during COVID-19 and the transition from DTU to their own facilities.

In addition Gerit shares some insights on co-founder dynamics, importance of work-life balance, fostering a trusting and transparent company culture, and navigating the startup world with authenticity.

About Chromologics

Chromologics is a Danish biotech start-up responding to the strong market pull for novel natural food colorants. We develop fungal fermentation solutions for the production of natural pigments. Our proprietary production process allows not only for a more sustainable production than existing solutions, but is also cost-competitive. Our pigments are produced by a non-GMO fungus, which makes them compliant with the dietary requirements of broad consumer bases such as kosher, halal, and vegan diets.

Timestamp & Shownotes

00:41 Who is Gerit Tolborg⁠

01:54 The Birth of Chromologics

03:06 Challenges and Opportunities in the Food Color Industry

03:57 The Journey of Chromologics: From Idea to Reality

04:58 The Role of Fermentation in Color Production

06:23 The Discovery of a New Molecule

07:28 The Path to Founding a Company

08:35 The Challenges of Transitioning from Academia to Business

10:03 The Importance of Building Relationships

10:55 The Journey of Fundraising and Scaling

12:48 The Challenges and Successes of Hiring and Growing a Team

14:39 The Impact of COVID-19

16:15 The Role of Business Acceleration Academy in the Company's Growth

26:26 Securing Investments and Navigating Lockdowns

28:30 Building a Team and Overcoming Hiring Challenges

30:00 Establishing Company Culture and Values

31:47 Balancing Work and Personal Life in a Startup

34:17 The Dynamics of a Co-Founder Relationship

36:34 Lessons Learned and Advice for Future Entrepreneurs

46:00 The Importance of Industry Experience and Thinking

48:08 Building a Supportive Network in the Startup World

49:47 Current Needs and Opportunities for Collaboration

𝗕𝗲𝗰𝗼𝗺𝗲 𝗽𝗮𝗿𝘁 𝗼𝗳 𝘁𝗵𝗲 𝗟𝗶𝗳𝗲 𝗦𝗰𝗶𝗲𝗻𝗰𝗲 𝗧𝗮𝗹𝗲𝗻𝘁 𝗘𝗰𝗼𝘀𝘆𝘀𝘁𝗲𝗺:

We want to build a community to inspire life science professionals and leaders through talent talks and organized events. Share knowledge across the life science community through personal stories of their journey. We encourage you to take part in shaping this community by sharing your feedback, questions, or ideas. This you can do through our LinkedIn⁠⁠⁠⁠ ⁠community page⁠⁠⁠⁠⁠⁠.

𝗚𝗲𝘁 𝗶𝗻 𝘁𝗼𝘂𝗰𝗵 𝗯𝘆 𝘃𝗼𝗶𝗰𝗲𝗺𝗮𝗶𝗹 𝗼𝗿 𝗟𝗶𝗻𝗸𝗲𝗱𝗜𝗻:

Feel free to share your thoughts and your feedback using our voicemail you can access⁠ ⁠⁠⁠⁠⁠here⁠⁠⁠⁠⁠⁠: (no voicemails will be published without your explicit approval).

Warm Regards from your podcast hosts:

⁠⁠⁠⁠Nehar Mortuza⁠⁠⁠⁠⁠⁠⁠ and ⁠Søren Spanner Bach⁠⁠⁠⁠⁠⁠

The theme of this episode is "A Four-Day Work Week In A Clinical Stage Drug Development Scale-up"

In this engaging conversation, Christian Grøndahl⁠, CEO and co-founder of SNIPR Biome - a CRISPR company discusses the differences in leadership approaches required in large vs small biotech companies.

Christian also provides advice for leaders considering the leap from large organisations to small startup ventures, and shares insights on developing new medicines, his drive to tackle antimicrobial resistance, and the critical role of CRISPR technology.

Timestamps

00:05 Introduction and Background

00:59 Journey from Veterinarian to Medicine

01:43 Introduction to Sniper Biome

02:13 Mission and Progress of Sniper Biome

03:45 The Role of CRISPR Technology in Medicine

04:42 First Leadership Role and Transition

06:58 Leadership Journey at Novo Nordisk

16:39 Transition to Biotech and Entrepreneurship

22:03 Challenges and Successes in Biotech

25:18 The Vision and Future of Sniper Biome

28:05 The Importance and Challenges of Antibiotics

28:44 The Impact of Climate Change and Biodiversity Loss

29:17 The Struggles of Raising Venture Capital for New Antibiotics

30:28 Leadership Challenges in a Biotech Startup

31:53 The Role of Big Pharma and Biotech Startups

33:14 The Importance of Innovation and Risk-Taking in Biotech

36:08 The Challenges of Hiring and Building a Team in Biotech

36:11 The Potential of CRISPR Technology and Antimicrobial Resistance

41:04 The Value of Learning and Taking Risks in Biotech

51:17 The Future of Biotech and the Importance of Pivoting

𝗕𝗲𝗰𝗼𝗺𝗲 𝗽𝗮𝗿𝘁 𝗼𝗳 𝘁𝗵𝗲 𝗟𝗶𝗳𝗲 𝗦𝗰𝗶𝗲𝗻𝗰𝗲 𝗧𝗮𝗹𝗲𝗻𝘁 𝗘𝗰𝗼𝘀𝘆𝘀𝘁𝗲𝗺:

We want to build a community to inspire life science professionals and leaders through talent talks and organized events. Share knowledge across the life science community through personal stories of their journey. We encourage you to take part in shaping this community by sharing your feedback, questions, or ideas. This you can do through our LinkedIn⁠⁠⁠ ⁠community page⁠⁠⁠⁠⁠.

𝗚𝗲𝘁 𝗶𝗻 𝘁𝗼𝘂𝗰𝗵 𝗯𝘆 𝘃𝗼𝗶𝗰𝗲𝗺𝗮𝗶𝗹 𝗼𝗿 𝗟𝗶𝗻𝗸𝗲𝗱𝗜𝗻:

Feel free to share your thoughts and your feedback using our voicemail you can access⁠ ⁠⁠⁠⁠here⁠⁠⁠⁠⁠: (no voicemails will be published without your explicit approval).

𝗙𝗼𝗹𝗹𝗼𝘄 𝘂𝘀:

⁠⁠⁠⁠⁠Nehar Mortuza⁠⁠⁠⁠⁠ and⁠⁠⁠ ⁠Søren Spanner Bach⁠⁠⁠⁠⁠

This episode has kindly been sponsored by ⁠⁠PharmaDanmark⁠⁠.

This episode was recorded 11 September 2023.

The theme of this episode is "A Four-Day Work Week In A Clinical Stage Drug Development Scale-up"

In this engaging conversation, Martin Rose, a proud farther and the CEO and co-founder of Tetra Pharm Technologies, shares talks about their 4-day workweek and unique leadership style that puts people first. Martin explains how his background in psychology shaped his approach to leadership and stresses the benefits of focusing on a person's strengths rather than their weaknesses.

Timestamps and highlights:

00:00 Introduction and Background

00:12 Understanding People-Centric Leadership

03:35 The Role of Trust in Leadership

04:35 The Concept of Servant Leadership

07:09 The Evolution of Leadership Style

08:45 The Introduction of a Four-Day Work Week

09:35 The Impact of a Four-Day Work Week

20:26 The Challenges and Benefits of a Four-Day Work Week

24:53 Advice for Leaders Considering a Four-Day Work Week

28:07 Unlocking Creativity Through a Four-Day Work Week

30:31 The Power of Focusing on Individual Strengths

31:30 Individualized Leadership and Task Assignment

33:53 Hiring for Personality and Potential

36:52 Breaking Down Hierarchies and Silos

37:31 The Impact of Matching Tasks to Individuals

40:19 Building Trust and Understanding Through Communication

40:53 The Role of Personality Tests in Understanding Employees

47:55 Advice for Younger Self and Other Leaders

50:33 The Importance of Building a Strong Company Culture

51:15 Balancing Task Execution and Employee Well-being

𝗕𝗲𝗰𝗼𝗺𝗲 𝗽𝗮𝗿𝘁 𝗼𝗳 𝘁𝗵𝗲 𝗟𝗶𝗳𝗲 𝗦𝗰𝗶𝗲𝗻𝗰𝗲 𝗧𝗮𝗹𝗲𝗻𝘁 𝗘𝗰𝗼𝘀𝘆𝘀𝘁𝗲𝗺:

We want to build a community to inspire life science professionals and leaders through talent talks and organized events. Share knowledge across the life science community through personal stories of their journey. We encourage you to take part in shaping this community by sharing your feedback, questions, or ideas. This you can do through our LinkedIn⁠⁠ ⁠community page⁠⁠⁠⁠.

𝗚𝗲𝘁 𝗶𝗻 𝘁𝗼𝘂𝗰𝗵 𝗯𝘆 𝘃𝗼𝗶𝗰𝗲𝗺𝗮𝗶𝗹 𝗼𝗿 𝗟𝗶𝗻𝗸𝗲𝗱𝗜𝗻:

Feel free to share your thoughts and your feedback using our voicemail you can access⁠ ⁠⁠⁠here⁠⁠⁠⁠: (no voicemails will be published without your explicit approval).

𝗙𝗼𝗹𝗹𝗼𝘄 𝘂𝘀:

⁠⁠⁠⁠Nehar Mortuza⁠⁠⁠⁠ and⁠⁠ ⁠Søren Spanner Bach⁠⁠⁠⁠

This episode has kindly been sponsored by ⁠PharmaDanmark⁠.

This episode was recorded 16 November 2023.

Professor Paul Franks, head of the Department of Translational Medicine at the Nova Nordisk Foundation, shares his professional journey from being a professor to transitioning into Novo Nordisk Foundation. He shares insights on what his role at the foundation involves, the importance of precision medicine, and the transition away from academia.  Paul discusses the role of identity and power in leadership, advocating for diversifying opportunities in science and academia. He talks about his career path, first starting as a professional athlete, transitioning into medical research, and the importance of promoting diversity and creating a more inclusive workplace. Towards the end he reflects on his career decisions, his approach towards mentorship and leadership, and the relevance of maintaining a balance between hard work and keeping an open mind.

 

00:46 Introduction and Background

01:19 Role at the Nova Nordisk Foundation

01:59 Transition from Academia to Corporate

03:13 Identity Shift and Challenges

04:23 Defining New Identity and Role

06:25 Journey from Athlete to Scientist

12:16 First Leadership Role and Challenges

16:33 Importance of Diversity, Equity, and Inclusion

26:59 Promoting Intellectual Diversity

34:19 Reflections on Career and Leadership

39:37 Advice for Young Leaders

42:53 Closing Remarks

The theme of this episode is "Fostering an entrepreneurial ecosystem in academia"

In this episode, Andreas Hougaard Laustsen-Kiel, Professor heading up the Center for Antibody Technologies at DTU Bioengineering and serial entrepreneur, shares his approach to fostering an entrepreneurial culture in academia.

Andreas also introduces listeners to some networking opportunities in the STEM field - the Rising Entrepreneurs of Biobusiness and Life Sciences, also known as REBELS, and YATSI, the Young Academy of Technology, Science and Innovation.

Timestamps and highlights:

00:38 Introduction and Guest Background

02:05 Andreas' Journey into Entrepreneurship

03:15 Balancing Academia and Entrepreneurship

05:01 The Role of Co-founders in Entrepreneurship

06:22 Benefits of Having Companies Next to Professorship

12:09 The Drive and Motivation Behind Entrepreneurship

14:16 The Impact of Entrepreneurship on Society

18:17 The Role of Learning and Curiosity in Entrepreneurship

25:40 Creating an Entrepreneurial Culture in Academia

35:39 Challenges and Strategies in Balancing Creativity and Direction

39:39 Tips and Resources for Aspiring Entrepreneurs

43:45 Conclusion and Final Thoughts

𝗕𝗲𝗰𝗼𝗺𝗲 𝗽𝗮𝗿𝘁 𝗼𝗳 𝘁𝗵𝗲 𝗟𝗶𝗳𝗲 𝗦𝗰𝗶𝗲𝗻𝗰𝗲 𝗧𝗮𝗹𝗲𝗻𝘁 𝗘𝗰𝗼𝘀𝘆𝘀𝘁𝗲𝗺:

We want to build a community to inspire life science professionals and leaders through talent talks and organized events. Share knowledge across the life science community through personal stories of their journey. We encourage you to take part in shaping this community by sharing your feedback, questions, or ideas. This you can do through our LinkedIn⁠ ⁠community page⁠⁠⁠.

𝗚𝗲𝘁 𝗶𝗻 𝘁𝗼𝘂𝗰𝗵 𝗯𝘆 𝘃𝗼𝗶𝗰𝗲𝗺𝗮𝗶𝗹 𝗼𝗿 𝗟𝗶𝗻𝗸𝗲𝗱𝗜𝗻:

Feel free to share your thoughts and your feedback using our voicemail you can access⁠ ⁠⁠here⁠⁠⁠: (no voicemails will be published without your explicit approval).

𝗙𝗼𝗹𝗹𝗼𝘄 𝘂𝘀:

⁠⁠⁠Nehar Mortuza⁠⁠⁠ and⁠ ⁠Søren Spanner Bach⁠⁠⁠

This episode has kindly been sponsored by PharmaDanmark.

This episode was recorded 8 March 2023.

𝗧𝗵𝗲 𝘁𝗵𝗲𝗺𝗲 𝗼𝗳 𝘁𝗵𝗶𝘀 𝗲𝗽𝗶𝘀𝗼𝗱𝗲 𝗶𝘀 “𝗘𝘃𝗮𝘅𝗶𝗼𝗻; 𝗔 𝗠𝗼𝗱𝗲𝗿𝗻 𝗢𝗿𝗴𝗮𝗻𝗶𝘇𝗮𝘁𝗶𝗼𝗻𝗮𝗹 𝗚𝗼𝘃𝗲𝗿𝗻𝗮𝗻𝗰𝗲 𝗙𝗿𝗮𝗺𝗲𝘄𝗼𝗿𝗸: 𝗔 𝗗𝗲𝗰𝗲𝗻𝘁𝗿𝗮𝗹𝗶𝘇𝗲𝗱 & 𝗔𝘂𝘁𝗼𝗻𝗼𝗺𝗼𝘂𝘀 𝗛𝗼𝗹𝗮𝗰𝗿𝗮𝗰𝘆”

In this episode, Andreas Holm Mattsson Chief AI & Culture Officer and Founder at Evaxion Biotech A/S introduce the modern organizational governance framework which is very different from the traditional hierarchies that govern most companies in life science.

In this episode, Andreas shares the following:

▶ The founding story of Evaxion which goes all the way back to a basement in 2008.

▶ How Evaxion aspires to save lives with AI immunotherapies.

▶ Introduction of Evaxion’s decentralized & autonomous holacracy governance framework that works like a cell.

▶ Benefits and challenges of this governance model.

▶ Recommendations for how other innovative companies can create a similar operating model.

If you are more interested in learning about this organizational framework Andreas recommends reading Reinventing Organizations by Frederik Laloux.

𝗕𝗲𝗰𝗼𝗺𝗲 𝗽𝗮𝗿𝘁 𝗼𝗳 𝘁𝗵𝗲 𝗟𝗶𝗳𝗲 𝗦𝗰𝗶𝗲𝗻𝗰𝗲 𝗧𝗮𝗹𝗲𝗻𝘁 𝗘𝗰𝗼𝘀𝘆𝘀𝘁𝗲𝗺:

We want to build a community to inspire life science professionals and leaders through talent talks and organized events. Share knowledge across the life science community through personal stories of their journey. We encourage you to take part in shaping this community by sharing your feedback, questions or ideas. This you can do through our LinkedIn ⁠community page⁠⁠.

𝗚𝗲𝘁 𝗶𝗻 𝘁𝗼𝘂𝗰𝗵 𝗯𝘆 𝘃𝗼𝗶𝗰𝗲𝗺𝗮𝗶𝗹 𝗼𝗿 𝗟𝗶𝗻𝗸𝗲𝗱𝗜𝗻:

Feel free to share your thoughts and your feedback using our voicemail that you can access⁠ ⁠here⁠⁠: (no voicemails will be published without your explicit approval).

𝗙𝗼𝗹𝗹𝗼𝘄 𝘂𝘀:

⁠⁠Nehar Mortuza⁠⁠ and ⁠Søren Spanner Bach⁠⁠

Also, thanks to our podcast editor ⁠Shahnam Jilan⁠⁠

Logo design inspired by ⁠⁠Rafa⁠⁠

In this episode, Susanne Gløersen, founder of The Future of Fungi Award and Fungi Investment Collective, discusses her mission to build a global ecosystem fueled by fungi innovation. 

The conversation covers the multifaceted applications of fungi, from food and materials to packaging and environmental remediation.

Susanne shares the origins of her passion for fungi, the purpose and success of the Future Fungi Award, and the criteria for selecting award winners and investment opportunities. She emphasizes the role of fungi in addressing pressing environmental issues and the importance of collaboration and community in advancing fungi innovation. 

Additionally, Susanne dives into the workings of the Fungi Investment Collective, highlighting how it supports pioneering scientists and startups with funding and resources. 

Essential for anyone interested in sustainable innovation, this episode unveils the transformative potential of fungi and how it can drive us towards a more balanced and nature-cooperative economy.

Shownotes and Timestamps

00:55 Introduction and Overview of Fungi Innovation

01:55 Susanne's Background and Journey into Fungi

04:48 Mission and Vision for Fungi Innovation

06:38 The Future Fungi Award

08:07 Highlighting Award Winners and Their Innovations

15:06 Support and Collaboration Opportunities

19:22 Introduction to the Fungi Investment Collective

24:46 Building a Network of Science Venture Partners

25:30 Investment Priorities and Criteria

26:54 Funding Ranges and Case Dependency

27:54 Connecting with the Fungi Investment Collective

28:55 Opportunities for Aspiring Venture Partners

32:33 Proud Accomplishments and Network Effects

36:27 Challenges and Learnings as a First-Time Entrepreneur

41:12 Future of Fungi Innovation and Exciting Startups

46:33 Conclusion and Call to Join the Movement

Resources Mentioned:

Awards, Collectives, and Initiatives

- Fungi Investment Collective

- Venture Builder Pilot Program (for top scientists)

- The Mycelium Network (community concept)

Podcasts & Media

- The Future is Fungi Podcast

Notable Startups & Projects

- Jens Laurids Sørensen (battery out of fungi)

- Nova Biome (textile waste to bioactive compounds for cosmetics, in L'Oreal's accelerator)

- Line Kloster Pedersen, Visibuilt (Danish startup making mycelium binder for asphalt production)

- William Newell, Electromicrobial CO2 fixation project (Imperial College of London)

- Nomy (Norwegian Mycelium, feed for aquaculture)

- Michael Lever (German company, surfactants from fungi)

Conferences & Events

- ChangeNow (largest accessibility conference)

- IMC12 (International Mycology Congress)

- Brilliant Minds (an event where Obama and Malala have spoken)

Corporates & Partners

- L'Oreal (accelerator)

- Novo Holdings (jury pre-screening)

- SEB (Green Tech VC, large Nordic Bank)

Book Recommendations

-Entangled Life by Merlin Sheldrake

Other

- LinkedIn (The Fungi Investment Collective)

- Fungi Investment Collective website/contact form

- Email: Suzanne@fungiinvestmentcollective.com

Ideas for future podcast guests or themes? 💡

We want to co-create this podcast with you. We'd therefore love to hear your suggestions for future podcast guests or themes.

Feel free to share in a private message or leave a comment below 🙏🏼

(It's also ok to invite yourself 😉)

Join Our Life Science Talent Ecosystem

We want to build a community to inspire life science professionals and leaders through talent talks and organized events. Share knowledge across the life science community through personal stories of their journey. We encourage you to take part in shaping this community by sharing your feedback, questions, or ideas. This you can do through our LinkedIn⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠community page⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠.

Warm Regards from your podcast hosts: ⁠⁠⁠⁠⁠⁠⁠⁠

Nehar Mortuza⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ and⁠⁠⁠ ⁠⁠⁠Søren Spanner Bach

𝗧𝗵𝗲 𝘁𝗵𝗲𝗺𝗲 𝗼𝗳 𝘁𝗵𝗶𝘀 𝗲𝗽𝗶𝘀𝗼𝗱𝗲 “𝗦𝘁𝗮𝗿𝘁𝗶𝗻𝗴 𝗮 𝗰𝗼𝗻𝘀𝘂𝗹𝘁𝗶𝗻𝗴 𝗳𝗶𝗿𝗺 𝗮𝘀 𝗮𝗻 𝗲𝘅𝗽𝗲𝗿𝗶𝗲𝗻𝗰𝗲𝗱 𝗹𝗶𝗳𝗲 𝘀𝗰𝗶𝗲𝗻𝗰𝗲 𝗽𝗿𝗼𝗳𝗲𝘀𝘀𝗶𝗼𝗻𝗮𝗹”

In this episode Anna Polak-Anderson, CEO at AnRes Clinical, shares her career journey and offers an insider's perspective on her reflections on starting your own consulting firm as an experienced life science professional.

In this episode, Anna shares her perspectives on:

▶ Anna’s career story and journey to her current role.

▶ Introduction to AnRes and Anna’s considerations leading to making the move to start AnRes Clinical.

▶ We also discuss the differences between being a corporate employee and self-employment - from Anna’s perspective.

▶ The tasks that energize and drain Anna in her work.

𝗕𝗲𝗰𝗼𝗺𝗲 𝗽𝗮𝗿𝘁 𝗼𝗳 𝘁𝗵𝗲 𝗟𝗶𝗳𝗲 𝗦𝗰𝗶𝗲𝗻𝗰𝗲 𝗧𝗮𝗹𝗲𝗻𝘁 𝗘𝗰𝗼𝘀𝘆𝘀𝘁𝗲𝗺:

We want to build a community to inspire life science professionals and leaders through talent talks and organized events. Share knowledge across the life science community through personal stories of their journey. We encourage you to take part in shaping this community by sharing your feedback, questions or ideas. This you can do through our LinkedIn ⁠community page⁠⁠:

𝗚𝗲𝘁 𝗶𝗻 𝘁𝗼𝘂𝗰𝗵 𝗯𝘆 𝘃𝗼𝗶𝗰𝗲𝗺𝗮𝗶𝗹 𝗼𝗿 𝗟𝗶𝗻𝗸𝗲𝗱𝗜𝗻:

Feel free to share your ideas and your feedback using our voicemail that you can access⁠ ⁠here⁠⁠: (no voicemails will be published without your explicit approval).

𝗙𝗼𝗹𝗹𝗼𝘄 𝘂𝘀:

⁠⁠Nehar Mortuza⁠⁠ and ⁠Søren Spanner Bach⁠⁠

Also, thanks to our podcast editor ⁠Shahnam Jilan⁠⁠

Logo design inspired by ⁠⁠Rafa⁠⁠

This episode was recorded on 21 February 2023

In this inspirational podcast Anne-Marie Hall brings a fresh perspective to storytelling within Healthcare and Life Sciences. She is bursting with energy and ready to share her secrets to good storytelling. We discuss

▶ Anne-Marie’s 3 major transitions that helped build a career portfolio

▶ ‘Amazing Hall’ vs Anne-Marie Hall;  authentic storytelling backed by facts and data

▶ Seven Principles of True Storytelling (book)

▶ Founder's journey: Storytelling and building relations vs Elevator Pitch and performance

▶Non verbal storytelling - communicating with gratitude. Speaking from the heart

▶ Take Home message- believe in yourself and do not let external factors define you!

Book- True Storytelling: Seven Principles for an Ethical and Sustainable Change Management strategy by J.Larsen, D.M.Boje, L.Bruun

Enjoy,

Nehar & Søren

This episode was recorded on 22th March 2023

In this inspirational podcast Alex walks us through his career path, ML, AI and the importance of staying curious. He is passionate about ML and the discussion continues to 

• His role at Corti - Building a team behind a healthTech product using AI(NLP) for medical coding. A Strategic and Innovation role, includes Coding as well as managing a team.

• Corti is a Scale up company - doubling in size, in terms of number of people and market products, this brings new challenges associated with it.

• Definition of ML and AI for a novice like me

• Of course we had to talk about ChatGPT and Open source models - limitations, advantages, biases and ethical issues.

• His blog on “Getting out of your comfort zone” in 4 steps - 

• Make new connections

• Take action, make opportunities rather than waiting for it

• Embracing/Hanging in there - new things can be exhausting or uncomfortable

• Evaluate periodically

• Alex’s take home message is all about having a growth mindset! 

  
  

𝗕𝗲 𝗽𝗮𝗿𝘁 𝗼𝗳 𝘁𝗵𝗲 𝗟𝗶𝗳𝗲 𝗦𝗰𝗶𝗲𝗻𝗰𝗲 𝗧𝗮𝗹𝗲𝗻𝘁 𝗘𝗰𝗼𝘀𝘆𝘀𝘁𝗲𝗺:

We want to build a community to inspire life science professionals and leaders through talent talks and organized events. Share knowledge across the life science community through personal stories of their journey. We encourage you to take part in shaping this community by sharing your feedback, questions or ideas. This you can do through our LinkedIn ⁠community page⁠⁠:

𝗚𝗲𝘁 𝗶𝗻 𝘁𝗼𝘂𝗰𝗵 𝗯𝘆 𝘃𝗼𝗶𝗰𝗲𝗺𝗮𝗶𝗹 𝗼𝗿 𝗟𝗶𝗻𝗸𝗲𝗱𝗜𝗻:

Feel free to share your ideas and your feedback using our voicemail that you can access⁠ ⁠here⁠⁠: (no voicemails will be published without your explicit approval).

𝗙𝗼𝗹𝗹𝗼𝘄 𝘂𝘀:

⁠⁠Nehar Mortuza⁠⁠ and ⁠Søren Spanner Bach⁠⁠

Also, thanks to our podcast editor ⁠Shahnam Jilan⁠⁠

The episode was recorded on 24th March 2023

𝗧𝗵𝗲 𝘁𝗵𝗲𝗺𝗲 𝗼𝗳 𝘁𝗵𝗶𝘀 𝗲𝗽𝗶𝘀𝗼𝗱𝗲 𝗶𝘀: 𝗛𝗼𝘄 𝘁𝗼 𝗱𝗲𝘃𝗲𝗹𝗼𝗽 𝗮 𝗽𝗮𝘀𝘀𝗶𝗼𝗻-𝗯𝗮𝘀𝗲𝗱 "𝘀𝗶𝗱𝗲 𝗵𝘂𝘀𝘁𝗹𝗲" 𝘄𝗵𝗶𝗹𝗲 𝘄𝗼𝗿𝗸𝗶𝗻𝗴 𝗶𝗻 𝗮 "𝗿𝗲𝗮𝗹 𝗷𝗼𝗯".

In this episode, Mette Viberg Østergaard, Director of Translational Science @ Tribune Therapeutics and an independent consultant @ Research 5 Kidneys shares her insights on developing a passion-driven side hustle while working a "real job".

Mette will further share her story and reflections relating to:

• Her career journey and transition from academia to her industrial career starting as a specialist and gradually developing towards sales/marketing/business development and consulting.
• How pulling the plug and taking off time to reflect on her career has helped.
• What is Tribune Therapeutic doing and what's her role there?
• Why and how Mette started Research 4 Kidneys and what her services are within business development and consulting?
• How Mette is managing 2 jobs while writing a master's thesis at Copenhagen Business School?
• How R&D teams can benefit from a business development mindset.
• What are the benefits for an employer to allow its employees to engage in side hustles and why there's a need for new types of flexible employment contracts...
• Mette further shares what energize and drains her.
• At the end of the episode Mette shares a couple of reflections on what you can do if you want to start your own side hustle.

𝗕𝗲𝗰𝗼𝗺𝗲 𝗽𝗮𝗿𝘁 𝗼𝗳 𝘁𝗵𝗲 𝗟𝗶𝗳𝗲 𝗦𝗰𝗶𝗲𝗻𝗰𝗲 𝗧𝗮𝗹𝗲𝗻𝘁 𝗘𝗰𝗼𝘀𝘆𝘀𝘁𝗲𝗺:

We want to build a community to inspire life science professionals and leaders through talent talks and organized events. Share knowledge across the life science community through personal stories of their journey. We encourage you to take part in shaping this community by sharing your feedback, questions or ideas. This you can do through our LinkedIn ⁠community page⁠⁠.

𝗚𝗲𝘁 𝗶𝗻 𝘁𝗼𝘂𝗰𝗵 𝗯𝘆 𝘃𝗼𝗶𝗰𝗲𝗺𝗮𝗶𝗹 𝗼𝗿 𝗟𝗶𝗻𝗸𝗲𝗱𝗜𝗻:

Feel free to share your ideas and your feedback using our voicemail that you can access⁠ ⁠here⁠⁠: (no voicemails will be published without your explicit approval).

𝗙𝗼𝗹𝗹𝗼𝘄 𝘂𝘀:

⁠⁠Nehar Mortuza⁠⁠ and ⁠Søren Spanner Bach⁠⁠

Also, thanks to our podcast editor ⁠Shahnam Jilan⁠⁠

This episode was recorded on 15 March 2023